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What is the evidence that medical procedures which induce coughing or involve 
respiratory suctioning are associated with increased generation of aerosols and risk of 
SARS-CoV-2 infection? A rapid systematic review 
 
Summary 
The risk of transmission of SARS-CoV-2 from aerosols generated by medical procedures is a 
cause for concern. This rapid systematic review aimed to evaluate the evidence for aerosol 
production and transmission of respiratory infection associated with procedures that 
involve airway suctioning or induce coughing/sneezing. 
The review was informed by PRISMA guidelines. Searches were conducted in PubMed for 
studies published between 1/1/2003 and 6/10/2020. Included studies examined whether 
nasogastric tube insertion, lung-function tests, nasoendoscopy, dysphagia assessment or 
suctioning for airway clearance result in aerosol generation or transmission of SARS-CoV-2, 
SARS-CoV, MERS, or influenza. Risk of bias assessment assessed robustness of 
measurement, control for confounding and applicability to clinical practice. 
Eighteen primary studies and two systematic reviews were included. Three epidemiological 
studies found no association between nasogastric tube insertion and acquisition of 
respiratory infections. One simulation study found low/very low production of aerosols 
associated with pulmonary lung function tests. Seven simulation studies of endoscopic sinus 
surgery suggested significant increases in aerosols but findings were inconsistent, two 
clinical studies found airborne particles associated with the use of microdebriders/drills. 
Some simulation studies did not use robust measures to detect particles and are difficult to 
equate to clinical conditions. 
There was an absence of evidence to suggest that the procedures included in the review 
were associated with an increased risk of transmission of respiratory infection. In order to 
better target precautions to mitigate risk, more research is required to determine the 
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Background 
Available evidence suggests that SARS-CoV-2 is emitted from an infected person’s mouth or 
nose in small liquid particles as they breathe, speak, cough or sneeze.  Particles range in size 
from larger respiratory ‘droplets’ (>10 um) to smaller ‘aerosols’ (<10 um) and fine particles 
(<1 um).  Transmission mainly occurs during close contact when the virus is inhaled or 
inoculated onto the mouth, nose or eyes of a susceptible person and depends on the amount 
of viable virus present and the infection control measures that are in place.1 Current World 
Health Organisation (WHO) and United Kingdom (UK) advice is that contact and droplet 
precautions, with the use of fluid-resistant surgical masks for close contact, are recommended 
for care of patients with SAR-CoV-2 infection. Airborne precautions (including the use of N95, 
FFP2 or FFP3 respirators) are recommended when aerosol generating procedures (AGPs) are 
being performed. Although not supported by evidence, the WHO recognises that some 
healthcare workers may place high value on the potential benefits of respirators and wish to 
use them in settings without AGPs.1,2  
 
Historically, respiratory particles have been categorised as droplets which are deposited 
rapidly because of their mass and aerosols which are smaller and travel over longer 
distances.3,4 However, it is now recognised that there is a continuum of particle sizes and 
aerosols which can be generated by breathing, speaking and coughing and can be present at 
both short and long distances.5 The risk that aerosols are able to transmit infection is 
influenced by a range of other factors including the amount of virus in the particle, the speed 
and turbulence of emission, and properties of the ambient environment.6 Although particles 
< 10 um can remain airborne for longer than larger respiratory droplets (>10 um), in typical 
particle size distributions a relatively small portion of total volume are in this range. 
Establishing the risk of transmission of SARS-CoV-2 associated with respiratory aerosols 
therefore requires evidence derived from different study designs. Laboratory-based studies 










rather than actual routes of transmission, while clinical studies can provide evidence of actual 
transmission although are more difficult to conduct and interpret.    
 
Some medical or patient care procedures are thought to increase the generation of 
respiratory aerosols.  Following the SARS epidemic in 2003, the WHO defined ‘high-risk AGP’ 
as medical procedures that ‘have been reported to be aerosol-generating and consistently 
associated with an increased risk of pathogen transmission’ and recommended the 
application of enhanced precautions for staff performing them.8  The SARS-CoV-2 pandemic 
has raised concerns about a range of other medical procedures that have the potential to 
generate respiratory aerosols either as a result of the procedure or because of its propensity 
to induce coughing or sneezing in the patient.  
 
We undertook this review to evaluate whether medical procedures which induce 
coughing/sneezing or involve respiratory airway suctioning, generate infectious aerosols 
and are associated with a risk of transmission of respiratory infection, including SARS-CoV-2. 
The procedures under consideration have not been previously defined as high-risk aerosol 
generating procedure (HR-AGP) but have been highlighted by clinicians as procedures of 
concern.9 This review sought to evaluate evidence to determine if these procedures 
generate infectious aerosols and are associated with a risk of transmission of respiratory 
infection in order to inform guidance for healthcare professionals caring for patients with 
SARS-CoV-2. Two main questions were addressed: 
1. Does evidence suggest that medical procedures which induce coughing/sneezing 
or involve respiratory airway suctioning result in infectious aerosol production?  
2. And if yes, what is the associated risk of transmission of SARS-CoV-2? 
 
Methods 
As the assessment of evidence was required urgently to underpin guidance for use by 
healthcare professionals we adopted a rapid review approach, meaning that there was 
some deviation from standard systematic review procedures.10 For example, although we 
produced a protocol, we were not able register it on Prospero as data extraction began 










commences); the protocol has been published elsewhere for transparency.11 This rapid 
systematic review was informed by PRISMA guidelines. However, it should be noted that 
specific rapid review guidelines are not currently available.12  Therefore, to ensure 
transparency we provide a full account of the review procedures below.   
 
Search strategy 
Searches were conducted by an information specialist (CS) in PubMed for studies published 
between 1st January 2003 and 6th October 2020. The search terms are detailed in web-
appendix 1 and included terms reflecting aerosol generation and transmission from droplets 
and /or aerosols, respiratory secretions, coughing, sputum, and aerosols plus the set of 
procedures of interest (Table 1).  In addition, the references of included articles were 
examined to identify any additional studies.  
 
Inclusion/ exclusion criteria 
The population of interest was adults and children with or without clinically suspected or 
confirmed COVID-19 or other respiratory infection (SARS, MERS, and influenza) or a 
simulated exposure model (e.g. using human volunteers, cadavers etc). The exposure of 
interest was one or more of the ‘procedures of concern’ shown in Table 1.  The outcome of 
interest was the number and size of respiratory particles generated during the procedure 
and/or rate of infection with respiratory pathogens among exposed staff.  
 
Study designs eligible for inclusion were case reports, case series, case control, outbreak 
studies, intervention studies (all designs) and systematic reviews reporting a search strategy 
involving multiple databases and explicit inclusion criteria.  Studies were included if 
published in English from 2003. Only studies that reported original data were included, 
correspondence or comment pieces, in vitro and vaccine studies and predictive modelling 
studies were excluded.  
 
The underlying evidence is heterogeneous, including different types of studies, both surgical 
and epidemiological, some with limited numbers of studies and others without potentially 
confounding factors. However, because of the limited amount of evidence, the full range of 













Study selection  
Search results were screened using EPPI-Reviewer software.13  One reviewer (JT) screened 
all titles and abstracts assisted by machine learning to prioritise potentially relevant papers. 
A second reviewer then independently screened the titles and abstracts provisionally 
included by JT and the excluded titles and abstracts that machine learning identified as most 
likely to have been erroneously excluded. Disagreements were resolved by discussion. Two 
reviewers (GC, JW) then independently screened the full reports of included references 
(n=68) and there was no disagreement. Reference checking of papers flagged by the full-text 
screeners as potential sources of further evidence was undertaken by KS.   
 
Risk of bias, data extraction and synthesis 
In line with best practice, available time and consistency requirements of a rapid review, one 
reviewer (KS) extracted all the data and a sample of 20% of papers were checked by a second 
reviewer (AO).10,14 An independent panel reviewed all the papers and evidence tables to 
check the accuracy of the data and interpretation of the evidence.  
 
Risk of bias 
Since high quality evidence was unlikely to be available, evidence would be drawn from 
both experimental laboratory-based studies (such as cadaveric simulation studies) and 
observational studies of clinical practice.  Therefore, in line with recommendations for rapid 
reviews the quality assessment for each study was focused on factors most important for 
decision-making.10 AO, KS, JT and AS developed a bespoke risk of bias tool to assess each 
study according to a) the robustness of measurement, b) control for confounding and c) 
applicability to clinical practice. These dimensions are illustrated in Figure 1 below. Details 
of the assessment for each study are provided in the Evidence Tables (Tables 2 - 6) in the 
column ‘Study contribution/limitations’. 
 










A standardised data extraction form was developed in order to produce a summary of each 
study. These summaries were then collated in evidence tables for each of the procedures of 
interest (nasogastric tube insertion, pulmonary lung function testing, suctioning for airway 
clearance, dysphagia assessment and nasoendoscopic procedures). Data were extracted on 
the following dimensions:  
 Study details: Country, aim, design. 
 Procedures and measures: procedures performed (on, by, where, number of 
repetitions) outcome measure type (e.g. virus transmission, aerosol size, spread, 
density) and method (e.g. virus transmission confirmed by antibody test, or aerosols 
captured by photodocumentation, particle sizer).  
 Findings: Key conclusions and detailed findings e.g. relative risk of virus transmission 
with 95% confidence intervals, mean change in particle concentration etc.  
 Risk of bias assessment: as described above.  
 
The synthesis of study findings was organised according to each of the procedures of 
interest. Findings were narratively synthesised to examine if consistent patterns in the 
direction of effect could be identified. An overview of findings from systematic reviews 
involved examining the extent of relevant evidence and authors conclusions.   
 
Findings 
A total of 913 documents were identified in the search of which six were duplicates. A 
further three papers were identified from reference-checking and a further rapid systematic 
review published after the search was conducted. Following application of the inclusion 
criteria, 20 relevant papers were identified; 18 primary studies and two systematic reviews 
Figure 2). 
 
Overview of primary studies 
Nine of the 18 studies provided evidence on endoscopic sinus surgery15-23, six studies 
focused on suctioning for airway clearance23-28, four outpatient endoscopy22,23,30,31, two 
nasogastric tube insertion26,27 and one lung function testing32. None of the primary studies 










more of the six procedures of interest; the remainder included evidence on a wider range of 
procedures.  For this review we only extracted data on the procedures of interest.  
 
All studies aimed to determine whether procedures put healthcare workers (HCW) at risk, 
either by examining whether procedures generate aerosols or droplets15-25,28-32 or whether 
procedures are associated with infection risk.25,26,27 Some studies also evaluated whether 
one or more patient actions generated aerosols or droplets. Patient actions measured 
included coughing22,24,29,30,32, sneezing22,23,30, speech22,30, heavy breathing22, swallowing30, 
tongue protrusion30 and vomiting.29  Finally, several studies evaluated whether a range of 
devices are effective in reducing the spread of aerosols or droplets during procedures. 
Devices included masks23,24,25,29, drapes15,  smoke evacuation system19 and suctioning.19,20,21  
 
Fewer than half of the primary studies were clinically-based involving actual patients15,18,25-
28,31; the remainder were simulations of procedures under experimental conditions and 
involved volunteers30,32,22; cadavers17,19,20,21,22,23 ; human patient simulators24,29 or porcine 
tissue16. 
 
Measurement of outcomes 
Of three studies measuring transmission, one employed a measure of the presence or viral 
genome (PCR test), one a test for antibodies, and one antibody tests or case definitions. Of 
the 15 studies measuring aerosols / droplets almost half used an optical particle counter or 
sizer to capture data18,19,21,22,28,31,32. The remainder used a method to enhance visualisation 
of aerosols or droplets so that they could be captured using video or camera technology, 
including fluorescein dye15,17,20 ,23,29, smoke17,24 or green laser30. One study used both smoke 
and fluorescein dye17.  
 
Findings on nasogastric tube insertion (2 studies) 
Both studies employed a retrospective cohort design and examined the association between 
performing nasogastric tube insertion and SARS infection among HCW in Canada (Table 2).  
One study26 found that there was no evidence of an association between nasogastric tube 
insertion and SARS infection based on data from 32 nurses who were involved in the 










undertook high risk procedures and consistently wore N95 or fluid resistant surgical masks 
(FRSM), three (13%) acquired SARS compared with five of the nine nurses who did not 
consistently wear a mask (56%) (RR 0.23; 95% CI 0.07 to 0.78, p = 0.02).  Only three 
procedures were associated with a significant risk of SARS acquisition - intubation and 
suctioning prior to intubation (RR 4.2; 95%CI 1.58 – 11.4; p = 0.04) and manipulation of 
oxygen mask (RR 9.0; 95%CI 1.25 – 64.9; p<0.01). The second study27 of 625 healthcare 
workers who provided care to 45 patients with SARS who underwent intubation also found 
no evidence of an association between nasogastric tube insertion and SARS infection. This 
was based on a multivariate analysis of a range of clinical procedures performed by 624 
HCW who cared for 45 patients with SARS.  Most staff wore FRSM (82%), only 4% wore N95 
and 8% wore no mask. Twenty-six healthcare workers acquired SARS and the factors that 
were significantly associated with SARS acquisition were being a paramedic, having less 
infection control training, wearing less personal protective equipment and participation in 
administering non-invasive, fibreoptic or manual ventilation. 
 
The evidence from these studies relates to patients with SARS and there may therefore be 
differences in terms of risk of transmission to SARS-CoV-2. In one study26 the exposure to 
three patients with SARS occurred during a period of 6 to 14 days between admission and 
death, which reflects the period of peak viral load associated with SARS.35  The second study 
was focused on high-risk exposure to healthcare workers who provided care to SARS 
patients in the period 24 hours before to 4 hours after intubation.  Intubation is likely to 
present similar risks in patients with SARS-CoV-2.27 Whilst these studies contribute evidence 
about infection risk in real-world clinical practice, there are several limitations. Firstly, the 
studies do not provide evidence about whether the procedures generate airborne particles. 
Secondly, the studies used case records and participant recall; whilst case records may be 
robust it remains unclear which type of data are used to substantiate tube insertion and 
where the evidence relies on recall it may be at risk of recall bias. Thirdly, the design used in 
both studies is at high risk of confounding; in each study HCWs performed multiple 
procedures (not just nasogastric tube insertion) and it is unclear which (if any) are 
responsible for the infection and it cannot be ruled out that HCWs may have acquired the 











Findings on pulmonary lung-function testing (n=1 study) 
A study by Greening et al used a simulation design involving healthy volunteers to examine 
aerosol / droplet production following pulmonary lung-function tests (tidal breathing, 
forced expiratory volume, slow vital capacity (SVC) following inspiration from functional 
residual capacity, and SVC following inspiration from residual capacity) and association with 
coughing (see Table 3).32  The study found very low particle emission in tidal volume and 
SVC from functional residual capacity, and low emission during forced expiratory volume. 
Coughing resulted in the highest mass of exhaled particles compared with all other 
manoeuvres, with a 640% (95%CI 230-1570, P < .01) increase compared with SVC following 
inspiration from functional residual capacity.32 
 
Whilst the study provides evidence about aerosol / droplet generation from pulmonary 
lung-function tests there are several limitations. Firstly, the study used ‘healthy volunteers’ 
and it is unclear how aerosol production might be affected in those with lung conditions or 
with a viral infection. Secondly, in-line filters, which would be routinely used in lung function 
laboratories, were not used during these tests and these would effectively filter airborne 
particles. Thirdly, it is unclear how appropriate the Particles in Exhaled Air particle sizer / 
counter system used in this study was for measuring aerosols / droplets in patients with a 
virus; the authors note that it registers mostly small droplets from the small airways, and 
virus are likely to be present in droplets from both upper and lower respiratory tract. 
 
Findings on endoscopic sinus surgery (n=9 studies) 
Two studies were observations of clinical practice, examining aerosol / droplet generation 
among patients whose SARS-Cov-2 infection status is unknown15 or patients who have 
received a negative test result.18 Of the remaining seven studies, most were cadaveric 
simulations17,19,20,21,22,23, and one used porcine tissue16 (see Table 4). The findings from these 
studies were not consistent. 
 
Of the two clinical observations, one18 found that non-powered instrumentation was not 
associated with a significant increase in concentration of airborne particles compared with 
the pre-instrumentation level (mean change = 0.0253 particles/cm3 p = 0.34) but the 










particles/cm3, p=0.001; 0.0644 particles/cm3, p=0.001). 70.3% of all particles measured 
were at the smallest reported size of detection (0.3μm). The second clinical observation15 
found minimal contamination beyond the immediate surgical field.  
 
All seven simulation studies evaluated drilling, of which six reported that it resulted in 
significant increase in aerosol generation16,17,19-23 and one reported that it did not20. In 
contrast to Murr et al18, microdebriders evaluated in five simulation studies all reported no 
aerosol / droplet generation17,19,20,22,23 . Of five studies evaluating non-powered 
instruments, one reported significant aerosol / droplet generation compared with baseline 
(mean change 1.29 particles/cm3, p=0.001) and increase in smaller particles (0.30-
0.37μm)19.  The other four reported no aerosol / droplet generation16,20,22,23 . Of three 
simulation studies evaluating electrocautery, all concluded that it resulted in a significant 
increase in aerosol / droplet generation16,19,22 . Three simulation studies examined external 
activation of powered instruments17,20,23  with all three reporting some increase in 
generation of aerosols or droplets. Nasal suctioning did not generate significant airborne 
aerosols in range 1-10μm22 and using suction mitigated the increase in aerosols generated 
by drilling19,20,21  and a negative pressure masks technique was reported to eliminate large 
droplets and reduce small aerosol particle concentration by 98%17.  
 
None of the studies provide evidence in relation to patients with COVID-19 or other 
respiratory infections and each of the studies has some limitations. One clinical observation 
study18 appears to use robust measures and account for potential confounders, but the 
study by David et al 202015 does not. The cadaveric and porcine simulation studies do not 
account for patient factors such as breathing coughing, nasal secretions, etc and whilst 
some of these simulations appear to use robust measures and account for potential 
confounders many do not (see Table 4). 
 
Findings on outpatient nasendoscopyendoscopy (n=4 studies) 
One study conducted in the USA used a clinical observation design and examined aerosol / 
droplet generation among patients who have received a negative SARS-Cov-2 test result. 
The remaining three studies were simulations (one cadaveric and two healthy volunteers). 










diagnostic nasal endoscopy with a rigid endoscope was not associated with increased 
particle aerosolization, but that sinonasal debridement, endonasal non-powered and 
suction instrumentation were associated with increased particle aerosolization compared 
with pre-procedure levels (mean increase 0.0869 particles/cm3, 95%CI 0.029-0.144, 
p=0.005; 0.105 particles/cm3, 95%CI 0.050-0.1599, p=0.001). The three simulation 
studies22,23,30 all found evidence of droplet or aerosol formation during nasendoscopy and 
associated patient behaviours such as sneezing (see Table 5).  
 
None of the studies provide evidence in patients with COVID-19 or other respiratory 
infections and each of the studies had some limitations. The measuring device (an optical 
particle sizer) used in the clinical observation was not able to detect the smallest particles 
and this study provided limited information about the experimental setup and sampling 
location with respect to ventilation. The cadaveric and healthy volunteer simulation studies 
did not account for patient factors such as nasal secretions, fever etc. and not all used 
robust measures or accounted for potential confounders (see Table 5). 
 
Findings on suctioning for airway clearance (n=6 studies) 
Three studies used a retrospective cohort design, of which one evaluated SARS-Cov-2 
transmission among healthcare workers in the USA, and two SARS transmission among 
health care workers in Canada.  Two simulation studies (one from Hong Kong24 and one 
from the USA29) used non-human simulators to evaluate aerosol / droplet production and 
the final study involved a clinical observation of aerosol / droplet production among H1N1 
patients in the UK.  Heinzerling et al25 found that among seven HCW who performed airway 
suctioning on an infected patient without applying transmission-based precautions (e.g. use 
of mask) none developed SARS-Cov-2 infection. In the retrospective studies on SARS 
patients26  Loeb et al found that critical care nurses who assisted with suctioning before 
intubation of SARS patients were four times more likely to become infected than nurses 
who did not perform suction (RR 4.2 95%CI 1.58- 11.14, p=0.04). However, Raboud et al 
2010 found no evidence of association of suction for airway clearance with SARS infection in 
a study of exposure of 624 nurses. In the two simulation studies24,29 Chan et al found that 
coughing during oro-tracheal suctioning could produce substantial dispersion of potentially 










associated with a range of healthcare activities, found that suctioning was not associated 
with increased concentration of fluorescein in air relative to other general care activities e.g. 
bathing, intravenous access, physical examination and no contamination was found on face 
or face shield during suctioning.29 Finally, a clinical observation study on H1N1 pandemic 
patients found an increase in aerosol generation during respiratory/airway suctioning but 
this was not statistically significant (OR = 4.11 (0.50–34.0).28  The particle size generated 
during suctioning were smaller than those collected during baseline but the difference was 
not significant.  
 
Each study has limitations. The three transmission studies rely (at least in part) on 
participant recall to determine which procedures HCW performed, and as such are at risk of 
recall bias. These retrospective studies are also at high risk of confounding as HCW 
performed multiple procedures (not just suction for airway clearance) and it is unclear 
which (if any) are responsible for the infection, although Raboud et al27 did adjust for this in 
a regression analysis, and HCW may have acquired the infection from another source. 
Second, two of the three studies on aerosol / droplet generation are simulations and as such 
it is not clear how these correspond to real-world conditions, for example breathing and 
nasal secretions, and there are also concerns about the appropriateness of measures used 
in these studies. Finally, the clinical observation on H1N1 patients provides no details on 
what type of respiratory suctioning was involved and there was considerable variation 
between and within individuals in the emission of aerosolised RNA.  
 
Overview of systematic reviews 
Two systematic reviews were identified that included primary research and addressed the 
review questions (Table 6).33,34  One investigated the evidence for the risk of transmission of 
acute respiratory infections to healthcare workers caring for patient undergoing AGPs, 
including nasogastric tube insertion and suctioning.33 Limited evidence was found, findings 
were based on the two studies already considered by this review26,27 and it was conducted 
prior to COVID-19. The authors concluded that although both procedures might be 
associated with an increased risk of transmission the odds ratios were not statistically 











Thamboo et al34 undertook a systematic review of potential AGPs in otolaryngology – head 
and neck surgery during the COVID-19 pandemic in order to inform clinical 
recommendations.  The review found limited evidence in relation to nasoendoscopy and 
endoscopic surgery and identified some of the studies already included in this review.  The 
authors made assumptions about the risk associated with different particles size, evidence 
was assessed and weighted and the limitations of basing recommendations on evidence 
from small, descriptive case-series experimental studies or retrospective cohort studies was 
recognised. The authors concluded that evidence for potential aerosols from nasal 
endoscopy was low and for treatment of epistaxis was moderate. Evidence for nasal 




We identified and evaluated evidence for the generation of respiratory aerosols during 
nasogastric tube insertion, cardiopulmonary exercise and lung function tests, 
nasoendoscopy, swallowing assessment and oral suction and their association with risk of 
transmission of SARS-CoV-2 and similar respiratory infections.   
 
The evidence is predominantly derived from experimental simulation studies which used 
optical particle counters or digital photography to measure respiratory particle 
dissemination or attempted to simulate droplets with fluorescein or aerosols with smoke. 
Some studies used cadavers or porcine tissue where the background effects of breathing 
and nasal secretions would not be accounted for, with only three studies30,32,22 based on 
healthy volunteers where behaviour such as coughing and sneezing could be evaluated.  
These simulation studies had important limitations in terms of the reliability of the 
measurement method in accurately detecting a wide range of particle sizes, some did not 
adjust for background levels or position counters to capture exposure to the operator, and 
the extent to which the simulation reflects actual aerosol generation is unknown.  Four 
studies based on clinical observation were more likely to reflect a real-life situation; one 
found a non-significant increase in aerosols associated with suctioning, two a significant 










debridement, but another study found minimal spread of particles beyond the endonasal 
surgical field.  
Although simulation studies provide some evidence of the potential for airborne respiratory 
particles to be generated from these procedures, the presence of aerosols does not prove 
an increased risk of transmission of respiratory viruses.  In order to demonstrate a clinically 
significant risk of airborne infection, aerosols must contain enough infectious virus to enable 
an infective dose to reach the specific host cell tissue that the virus is able to infect.36 The 
evidence needs to demonstrate a significant increase in aerosols compared with background 
levels and that the aerosols are able to carry virus and transmit infection.  
Only one study on oral suctioning28 set out to detect influenzas virus in respiratory particles 
but did not attempt culture to establish if the particles could transmit infection. 
Epidemiological evidence from studies that explored the risk of developing respiratory 
infection in personnel who performed the procedure is limited and only found for 
nasogastric tube insertion and suctioning.  These studies did not demonstrate an association 
between performing these procedures and the risk of SARS, although the risk may be 
different in relation to SARS-CoV-2.  
 
The potential for respiratory infections to transmit by an airborne route is dependent on a 
complex set of parameters which influence the generation and behaviour of respiratory 
particles. Conventionally, airborne particles have been distinguished as droplets which settle 
rapidly because of their mass, and aerosols which evaporate to form droplet nuclei and 
travel longer distances.37,3  Droplets were perceived to be the primary risk of transmission 
when a susceptible person is in close proximity.4,8 
 
However, it is now recognised that the dynamics are more complex and affected by a 
number of factors including force and volume of exhalation as well as humidity, 
temperature and airflow in the surrounding environment which affect the rate of 
evaporation and dissemination of particles.6  Natural respiratory activities such as breathing 
and talking can generate a broad range of particle sizes, from submicron aerosols to large 










Gregson et al (2020)5 found an association between amplitude of speaking or singing and 
increased concentration of short-range aerosols but also a significant variation in particle 
emission between individuals.  Indeed, results from different studies on the fluid dynamics 
of respiratory particles vary by orders of magnitude reflecting both the complexity of the 
phenomenon and approaches to measurement.6  
 
One of the concerns related to the procedures included in this review was their tendency to 
induce coughing.  The mechanism by which coughing generates respiratory particles 
involves high-speed airflow over the mucus lining the airway and this generates a higher 
concentration of respiratory particles compared with speaking.7 The initial particle cloud has 
a high concentration of droplets which settle rapidly. The smaller particles remain in 
suspension and travel further. The evaporation of smaller droplets into droplet nuclei 
depends on the ambient temperature and relative humidity.38  However, given the greater 
mass of droplets expelled by either coughing or speaking these particles contain a high 
proportion of the fluid, and therefore virus, expelled. The amount of virus expelled will also 
depend on the viral load which will vary depending on the severity of the infection and 
specific regions of the respiratory tract that are affected.7   
 
The competing risks of more virus in larger droplets at lower concentration versus a higher 
concentration of smaller droplets with lower viral load have not been well studied for 
coughing. However, the risk of being exposed to an aerosol containing virus appears to be 
lower than the risk due to larger droplets at close range.  The added risk of being exposed to 
a virus-containing aerosol particles from an aerosol generating medical procedure appears 
to be low relative compared with the general risk of exposure to expiration from a patient.  
In a light-scattering study the authors estimated that during 1 min of loud speaking at least 
1,000 virion-containing droplet nuclei would be generated and remain airborne for more 
than 8 min.  Nevertheless, at a saliva viral load of 7×106 copies per millilitre the probability 
that a 3μm droplet nucleus contains a virion is only 0.01%.39 Viral emissions associated with 
coughing are likely to be considerably higher than for breathing40 with more virus being 
contained in larger droplets, which present a greater risk during close contact rather than 










absence of AGPs is not fully understood and the additional risk posed by AGPs whether as 
aerosols or droplets, is difficult to distinguish from general patient interaction.  
 
The generation of the aerosol is only one component of the chain of infection, with the 
quantity and stability of the virus and susceptibility of the host also being key to 
transmission.6,36  The particle must be able to enter or be transferred onto the mucous 
membranes of the host and carry a sufficient number of viable virus to by-pass the host 
human defences, including the mucus coating the cell surface.  Whilst experimental studies 
have explored the dynamics of respiratory particles, these viral and host parameters 
determining the risk of infection are less well understood.  In addition, environmental 
factors such as the proximity of susceptible individuals and the duration of exposure, the 
size of the indoor environment and its ventilation, as well as hygiene practices and the 
presence of surfaces that play a role in indirect contact will also be important in 
transmission.    
 
There are few other systematic evidence reviews that address these medical procedures. 
One was conducted prior to the COVID-19 pandemic.  It informed the concepts of high risk 
AGPs and drew similar conclusions to our review in relation to nasogastric tube insertion 
and suctioning.33 There is only one robust review related to SARS-CoV-2, this is focused on 
nas(o)endoscopy and, although did not identify all the evidence included in this review, 
drew similar conclusions.34  
 
Overall, we identified an absence of evidence to suggest that these procedures are 
associated with additional risk of transmission of respiratory viruses beyond standard 
patient interactions.  For pulmonary function tests, very low levels of particle emission were 
detected in the one study on lung function tests. Coughing was associated with emission of 
large particles which are more likely to equate to droplets than aerosols. Similarly, two 
simulation studies found no significant increase in aerosol generation or contamination of 
the face associated with suctioning of the respiratory tract.  Findings from simulation 
studies on nasoendocopy suggested a significant increase in aerosols but findings were 
inconsistent, probably reflecting the use of different models (cadaveric, porcine or human 










measures in some cases, and uncertainty about whether fluorescein and smoke are 
adequate surrogates for the generation of human respiratory particles.  In addition, these 
simulation studies are difficult to equate to clinical conditions and did not account for 
patient factors such as coughing and were vulnerable to confounding.  The limited evidence 
available from studies of virus emission or evidence of transmission associated with 
conducting these procedures did not demonstrate a risk of transmission, although their 
retrospective design makes them vulnerable to bias and confounding. Given the absence of 
evidence it is not possible to establish a clear absence of risk associated with these 
procedures.   
 
Coughing may be a risk factor for transmission. However, although this has been 
investigated experimentally in terms of aerosol generation, an association with infection 
transmission has not been demonstrated.  Aerosol generation (<10um) associated with 
coughing appears to be at a relatively low level but is highly variable. Epidemiological 
evidence suggests that the specific characteristics of the patient are a critical factor in 
driving transmission as a large proportion of transmission to both other patients and staff 
appears to be related to only a small number of patients.42,43 Exposure during early stage in 
infection when viral load is highest is a key factor in driving risk and needs to be considered 
in terms of identifying risk to healthcare workers.43   
 
The most recent WHO guidance on the use of masks in healthcare settings acknowledged 
that whilst respirators are recommended primarily for settings where AGPs are performed, 
some healthcare workers have strong preferences about having the highest perceived 
protection.  However, whilst personal protective equipment such as N95/FFP3 respirators 
have a role to play in protecting against inhalation of aerosolised particles, administrative 
and engineering controls remain priority components of infection prevention and control.  
Strategies to ensure that patients with SARS-CoV-2 are segregated to allow non-urgent 
procedures to be conducted when no longer infectious and that procedures are conducted 
in well ventilated areas are key to mitigating the potential risk from aerosols.2 
 
Evidence suggests that the risk of transmission of SARS-CoV-2 to healthcare workers may be 










Aerosols have been assumed to be the explanation for the association between a small 
number of respiratory tract procedures such as tracheal intubation, non-invasive and 
manual ventilation, and risk of transmission to healthcare workers performing them.33 This 
potential route of transmission has subsequently been applied to a wider set of procedures, 
for which expert consensus has assumed a similar risk of exposure to respiratory aerosols, 
and these are defined as high risk AGP.1,45  However, evidence for aerosols being generated 
during some procedures designated as AGP is absent or equivocal.41,44 It is therefore possible 
that other factors such as very close and prolonged contact with respiratory secretions 
might play a role in increasing the risk of transmission.33,44  Uncertainty about the link 
between medical procedures and risk of transmission to healthcare workers is 
demonstrated by the significant inter-country variation in designation of medical procedure 
as AGPs.46 
 
The paradigm for AGPs needs further consideration to better combine evidence from 
aerosol and infection prevention and control science. More research is required to 
determine the characteristics of both medical procedures and patients that increase the risk 
of transmission in order to better target precautions to mitigate the risk.  
 
Limitations of review 
This review was limited in scope and because undertaken within a short timeframe was 
restricted to publications in PubMed. However, this would be expected to capture the main 
publications on this topic and references from the included studies and other systematic 
reviews were assessed to help mitigate this.  Findings related to other respiratory viruses 
may not be comparable with SARS-CoV-2 because of difference in transmission dynamics. 
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Figure 1:  Elements considered in the risk of bias evaluation  
Notes. AG = aerosol generating; AGPs = aerosol generating procedures; AGB = aerosol generating behaviours; 
PPE = personal protective equipment. The rectangles labelled RQ1 and RQ2 show the parts of the model that 
were explored by research question 1 and research question 2, respectively. The orange area of overlap 
between these rectangles indicates the intersection of the foci of the two research questions in relation to 
aerosol production. RQ1: Does evidence suggest that medical procedures which induce coughing or involve 
respiratory airway suctioning result in infectious aerosol production? RQ2: If yes, what is the associated risk of 
transmission of SARS-CoV-2? The grey box labelled “Not covered in the literature” refers to the evidence base 
at the time of the searches were conducted (Oct, 2020). 
 














Web Appendix 1: Search terms 
Pubmed Search (legacy interface)  
6/10/20 
(((((Deglutition Disorders/diagnosis[mh] OR ((videofluoroscopy[Title/Abstract] OR 
fluoroscopy[Title/Abstract] OR endoscopy[Title/Abstract] OR endoscopic[Title/Abstract] OR 
endoscopic[Title/Abstract] OR Laryngoscop*[Title/Abstract] ) AND (swallow[Title/Abstract] OR 
swallowing[Title/Abstract] OR nasal[Title/Abstract] OR sinonasal[Title/Abstract] OR 
nose[Title/Abstract] OR dysphagia[Title/Abstract])) OR (dysphagia[Title/Abstract] AND 
(assess[Title/Abstract] OR examine[Title/Abstract] OR assessment[Title/Abstract] OR 
assessing[Title/Abstract] OR examination[Title/Abstract] OR procedure[Title/Abstract] OR 
procedures[Title/Abstract])) OR ((Otorhinolaryngologic Surgical Procedures[Title/Abstract] OR 
Otorhinolaryngologic Surgical Procedures[mh]) AND (swallow[Title/Abstract] OR 
swallowing[Title/Abstract] OR nasal[Title/Abstract] OR sinonasal[Title/Abstract] OR 
nose[Title/Abstract] OR dysphagia[Title/Abstract])) OR Intubation, Gastrointestinal[Mesh] OR 
Rehabilitation of Speech and Language Disorders[Mesh] OR airway clearance*[Text Word] OR "clear 
airways"[Text Word] OR (clear*[Text Word] airway*[Text Word]) OR "clearing airways"[Text Word] OR 
"clearing airway"[Text Word] OR airway control[Title/Abstract] OR suction*[Title/Abstract] OR 
dysphagia assessment*[Text Word] OR swallow*[Text Word] OR cough reflex test*[Text Word] OR 
mechanical aspiration[Title/Abstract] OR ((reflex OR reflexes OR reflexive)[Title/Abstract] AND 
coughing[Title/Abstract]) OR forceful coughing[Text Word] OR prolonged coughing[Text Word] OR 
fibreoptic endoscopic evaluation*[Text Word] OR Suction[Mesh] OR Airway Extubation[mh] OR 
Airway Management[mh:noexp] OR airway control[Title/Abstract] OR airway 
management[Title/Abstract])) OR (Respiratory Function Tests[Mesh] OR Exercise Test[Mesh] OR 
Spirometry[Mesh] OR respiratory function test*[Text Word] OR pulmonary function test*[Text Word] 
OR lung function test*[Text Word] OR exercise test*[Text Word] OR fitness test*[Text Word] OR arm 
ergometry test*[Text Word] OR step test*[Text Word] OR stress test*[Text Word] OR treadmill 
test*[Text Word] OR eurofit test*[Text Word] OR bicycle ergometry test*[Text Word] OR walk 
test*[Text Word] OR spirometr*[Text Word] OR bronchospirometr*[Text Word])) OR (Diagnostic 
Techniques, Respiratory System [mh] OR (((Pulmonary[Title/Abstract] OR respiratory[Title/Abstract] 
OR lung[Title/Abstract]) AND Function Test*[Title/Abstract]) OR Exercise tolerance 
test*[Title/Abstract] OR cardiac physiology[Title/Abstract]) OR (((((ESOPHAGUS[mh] AND 
INTUBATION[mh]) OR Intubation, Intratracheal[mh] OR intubation[Title/Abstract] OR 
endoscopic[Title/Abstract] OR endoscopy[Title/Abstract]) AND (nose OR nasogastric OR nasal OR 
sinonasal OR naso gastric)) OR (Natural Orifice Endoscopic Surgery[MeSH Terms] AND (nose[MeSH 
Terms] OR nasal[Title/Abstract] OR sinonasal[Title/Abstract] OR nose[Title/Abstract] OR 
nasogastric[Title/Abstract] OR naso gastric[Title/Abstract])) OR ((cautery[MeSH Terms:noexp] OR 
cautery[Title/Abstract]) AND (nose[MeSH Terms] OR Nasal Surgical Procedures[MeSH Terms] OR 
nasal[Title/Abstract] OR sinonasal[Title/Abstract] OR nose[Title/Abstract])) OR 
(Nasoendoscopy[Title/Abstract] OR Naso endoscopy[Title/Abstract] OR nasogastric tube*[Text Word] 
OR "naso gastric tube"[Text Word] OR "naso gastric tubes"[Text Word] OR nasogastric 
intubation*[Text Word] OR gastrointestinal intubation*[Text Word])))))) AND (((("unexpected 
exposure"[Text Word] OR "disease transmission"[Text Word] OR "Infection Transmission"[Text Word] 
OR "Infection Transmission" OR "Pathogen Transmission"[Text Word] OR "risk of transmission" OR 
"viral transmission"[Text Word] OR "cross infect"[Text Word] OR "cross-infect"[Text Word] OR "cross 
infects"[ Text Word] OR "cross-infects"[Text Word] OR "cross infection"[Text Word] OR "cross-








spread"[Text Word] OR "droplet spreading"[Text Word] OR droplet emission*[Text Word] OR 
aerosol[Text Word] OR aerosols[Text Word] OR aerosoli*[Text Word] OR droplets[Text Word] OR 
(droplet[Text Word] AND splatter*[Title/Abstract] OR spread*[Title/Abstract]) OR droplet exposure*[ 
Text Word] OR "viral particle"[Text Word] OR "airborne" OR "air borne" OR particulate[Title/Abstract] 
OR particulates[Title/Abstract] OR "Airborne particulate"[Text Word] OR "Airborne particulates"[Text 
Word] OR "particulate generation"[Title/Abstract] OR "particle generation"[Title/Abstract] OR 
airborne[Title/Abstract] OR transmission[MeSH Subheading] OR guidance*[ti] OR guideline*[ti] OR 
recommend*[ti] OR risk*[ti]) AND (Coronavirus[mh] OR Coronavirus Infections[mh] OR coronavirus* 
or "corona virus" or "corona viruses" or OC43 or NL63 or 229E or HKU1 or HCoV* or ncov* or covid* 
or sars-cov* or sarscov* or Sars-coronavirus* or "Severe Acute Respiratory Syndrome" OR SARS OR 
"severe acute respiratory syndrome"[mh] OR "severe acute respiratory syndrome" OR "Middle East 
Respiratory Syndrome Coronavirus"[mh] OR "middle east respiratory syndrome" OR "middle east 
respiratory syndromes" OR "MERS-CoV" OR Mers OR "Middle Eastern Respiratory Syndrome" OR 
"Middle Eastern Respiratory Syndromes" OR MERSCoV* OR "COVID-19" or "2019-nCoV" or "SARS-
CoV-2" OR ((coronavirus*[Title/Abstract] OR coronovirus*[Title/Abstract] OR "2019-
nCoV"[Title/Abstract] OR "COVID-19"[Title/Abstract] OR "COVID 19"[Title/Abstract] OR "HCoV-
19"[Title/Abstract] OR CoV[Title/Abstract] OR ncov[Title/Abstract] OR "SARS-CoV-2"[Title/Abstract] 
OR (ncov*[Title/Abstract] AND wuhan[Title/Abstract]) OR "severe acute respiratory 
syndrome"[Title/Abstract] OR "sudden acute respiratory syndrome"[Title/Abstract] OR 
SARS[Title/Abstract] OR MERS[Title/Abstract] OR "Middle East Respiratory Syndrome"[Title/Abstract] 
OR influenza[Title/Abstract] OR flu[Title/Abstract]) OR ((("Coronavirus"[Mh] OR "Coronavirus 
Infections"[Mh] OR "Middle East Respiratory Syndrome Coronavirus"[Mh]) OR "Severe Acute 
Respiratory Syndrome"[Mh]) OR "Influenza, Human"[Mh])))) OR ((infect[Title/Abstract] OR 
infecting[Title/Abstract] OR infectious[Title/Abstract] OR infect*[Title/Abstract] OR 
exposure[Title/Abstract] OR transmission[Title/Abstract] OR transmission[Title/Abstract] OR "disease 
transmission"[Title/Abstract] OR "Infection Transmission"[Title/Abstract] OR "Infection 
Transmission"[Title/Abstract] OR "Pathogen Transmission"[Title/Abstract] OR "risk of transmission" 
OR "viral transmission"[Text Word] OR cross infect*[Text Word] OR cross-infect*[Text Word]) AND 
(health personnel[mh] OR "healthcare worker"[Title/Abstract] OR health worker*[Title/Abstract] OR 
health care worker*[Title/Abstract] OR "health care staff"[Title/Abstract] OR "healthcare 
staff"[Title/Abstract] OR ENT specialist*[Title/Abstract] OR physiotherapist*[Title/Abstract] OR 
therapist*[Title/Abstract] OR "health personnel" [Title/Abstract] OR "health care personnel" 
[Title/Abstract] OR "healthcare personnel"[Title/Abstract] OR clinician*[Title/Abstract] OR health 
professional*[Title/Abstract] OR healthcare professional*[Title/Abstract] OR health care 
professional*[Title/Abstract] OR Otorhinolaryngologists[Title/Abstract] OR 
Otolaryngologists[Title/Abstract] OR surgeons[Title/Abstract] OR "surgical staff"[Title/Abstract])) OR 
(("unexpected exposure" OR transmission[Title/Abstract] OR "disease transmission" OR "Infection 
Transmission" OR "Infection Transmission" OR "nosocomial infection" OR "hospital transmission" OR 
"nosocomial transmission" OR "Pathogen Transmission" OR "risk of transmission" OR "viral 
transmission" OR "cross infect" OR "cross-infect") AND (risk[Title/Abstract] OR risks[Title/Abstract] OR 
"risk factors"[mh])) OR ("Cross Infection"[mh] OR "Disease Transmission, Infectious"[mh] OR 
Occupational Exposure[mh]))) AND ((Aerosols[MeSH Terms] OR (droplet[Title/Abstract] OR 
droplets[Title/Abstract] OR cough*[Title/Abstract] OR sputum*[Title/Abstract] OR "respiratory 
secretion"[Title/Abstract] OR "respiratory secretions"[Title/Abstract] OR aerosol*[Text Word] OR 
airborne[Text Word] OR AGP[Text Word] OR AGPs[Text Word] OR "Aerosols"[Mesh] OR "Air 
Microbiology"[mh] OR particulates OR "particulate generation"[Title/Abstract] OR "particle 








Table 1: Procedures of concern in relation to generation of infectious aerosols 
Nasogastric tube insertion 
Cardiopulmonary and lung function tests, cardiopulmonary exercise test, spirometry, 
cardiac physiology procedures  
Swallowing assessment related to dysphagia including endoscopic and fluoroscopy 
Suction of the upper airway in the context of airway clearance  













Table 1: Primary research on nasogastric tube insertion (n=2 studies) 
 Study details Procedures and measures Findings  Study limitations / contribution 
1 Study: Loeb (2004)26  
Country: Canada  
Aim: “To determine 
risk factors for SARS 
among nurses who 
worked in two critical 





On: SARS patients (n=3) 
By: Usual clinician (Nurses) 
(n=32) 
Where: Hospital ward / room 
Procedure repetitions: n=8 
Outcome measures: 
Measure: Virus transmission 
Method: Confirmed by 
antibody test.  
Key finding: No evidence of 
association of nasogastric tube 
insertion with SARS infection.  
Details: 33% of nurses who undertook 
nasogastric tube insertion were 
infected with SARS (2/6 nurses) 
compared to 23% of nurses who did 
not undertake nasogastric tube 
insertion (6/26 nurses). Relative risk 
1.44; CI 95% 0.38 to 5.47; P value 
0.62. 
Note: The authors report that of the 
32 nurses who entered a SARS 
patient’s room at least once 23 
consistently wore a mask (either 
surgical or N95) whilst the remaining 
9 did not. There is no specific 
information about mask use during 
nasogastric tube insertion. 
Is the study a reasonable representation of real-world clinical 
practice? Yes: clinically-based evaluation.  
Are measurement tools appropriate / robust? No: Risk of recall 
bias; procedure data are in part collected via interview and 
depend on how accurately nurses can recall what they did. 
Does the study design control for potential confounders? No: 
Nurses performed multiple procedures, including high risk 
AGPs, so unclear which (if any) are responsible for infections. 
No comparison of how much time nurses spend patient’s 
room. Nurses may have been infected by another source 
although SARS was not disseminated in the local community.  
Other concerns? Small sample size.  
2 Study: Raboud (2010)27  
Country: Canada  
Aim: “To identify risk 
factors associated with 
transmission of SARS-
CoV from patients 
requiring intubation to 
HCWs involved in their 
care.” 
Procedure(s) performed: 
On: SARS patients who were 
intubated (n=45) 
By: Usual clinician (various 
HCW) (n=624) 
Where: Hospital ward / room 
Procedure repetitions: n=47 
Key finding: No evidence of 
association of nasogastric tube 
insertion with SARS infection.  
Details: 8% of nurses who undertook 
nasogastric tube insertion of nurses 
were infected with SARS (2/26 
nurses) compared to 8% who did not 
undertake nasogastric tube insertion 
Is the study a reasonable representation of real-world clinical 
practice? Yes: clinically-based evaluation.  
Are measurement tools appropriate / robust? No: Risk of recall 
bias. Procedure data in-part from HCW recall – interviews 
conducted up to 10 months post-procedure.  Patient hospital 
records used to confirm when possible. 
Does the study design control for potential confounders? No: 
HCW didn’t necessarily perform procedure – considered 
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Measure: Virus transmission 
Method: Confirmed by 
antibody test or met case 
definition. 
(45/598 nurses). Fishers exact test p 
value = 0.99. 
In the multivariate logistic regression 
model (to account for correlation 
among HCWs caring for same 
patient) nasogastric tube insertion 
not found to be an independent 
predictor of SARS infection. 
Note: HCWs who contracted SARS 
were “more likely to have used less 
effective methods of respiratory 
protection while in a patient’s room 
(p= .04)”. There is no specific 
information about mask use during 
nasogastric tube insertion. 
procedure. HCW perform multiple procedures so unclear which 
(if any) are responsible for infection – although adjusted for in 
logistic regression. No information on duration of procedures, 
use of PPI in relation to specific procedures, length of time 
spent in patients’ room. HCW may have been infected by 
another source although SARS was not disseminated in the 
community. 
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Table 2: Primary research on lung function testing (n=1 study) 
 Study details Procedures and measures Findings  Study limitations / contribution 
1 Study: Greening (2020)32  
Country: UK 
Aim: To determine the 
mass of small droplets 
exhaled at varying flow 
rates and during different 
respiratory manoeuvres. 
Design: Simulation in 
healthy volunteers using 
particle counter 
Evidence:   
- Does procedure 
generates aerosols  
- Do patient behaviours 
generate aerosols 
 
Procedure(s) performed:  
Procedure(s) evaluated:  
- Tidal breathing 
- Forced expiratory volume 
- Slow vital capacity (SVC) 
following inspiration from 
functional residual capacity 
- SVC following inspiration 
from residual capacity 
Patient behaviour(s) 
evaluated:  
- Cough  
Device(s) evaluated: N/A 
On: Healthy volunteers (n=33) 
By: Not reported.   
Where: Not reported.   
Procedure repetitions: n=102 
Outcomes measured: 
Measure: Droplet emission 
Method: Optical particle 
counter (Particles in Exhaled 
Air (PExA)).  
Key finding:  
“Small droplet emission varies for different breath 
manoeuvre performed during PFT [pulmonary function 
tests], with very low production in TV [tidal volume] 
and sVC from FRC [functional residual capacity] and 
low production during FEV [forced expiratory 
volumne]” “Coughing is associated significant increase 
in particles.”   
Details:  
Tidal breathing: There was minimal increase in particle 
mass during tidal breathing compared with 
background noise (median mass per litre of breath 
0.09ng/l [IQR 0.09]) 
SVC (functional residual capacity): Median mass per 
litre of breath 0.4ng/l. 
Forced capacity volume: A higher particle mass 
production than SVC following functional residual 
capacity (+150%, 95%CI 10-470, P = .03). 
SVC (residual capacity): A significant increase in 
particle mass was seen with SVC following inspiration 
from residual capacity compared to SVC from 
functional residual capacity (+470%, 95%CI 150-1190, 
P < .01). 
Cough: Coughing resulted in the highest mass of 
exhaled particles compared with all other manoeuvres, 
with a 640% (95%CI 230-1570, P < .01) increase 
compared to Slow vital capacity following inspiration 
from functional residual capacity. 
Is the study a reasonable 
representation of real-world clinical 
practice? Unclear: Performed with 
‘healthy volunteers’, unclear how 
aerosol production might be affected 
in those with lung conditions or with a 
viral infection. Also authors note ‘The 
manoeuvres in this study do not meet 
current ERS/ATS spirometry 
standards.’ 
Most lung function laboratories will 
use in-line filters which would 
effectively filter airborne particles 
during these tests.  
Are measurement tools appropriate / 
robust? Unclear: Authors note that 
‘the PExA system registers mostly 
small droplets from the small airways, 
and virus are likely to be present in 
both upper and lower respiratory 
droplets.’ The measurement of 
particle mass means no data about 
particle size. 
Does the study design control for 
potential confounders? Yes: 
Manoeuvres were performed using 
particle free HEPA filtered inspiratory 
air, but no particle filter between 
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The authors note that manoeuvres 
also included a breath hold before 
exhalation which may result in lower 
flow rate and particle release. 
Table 3: Primary research on endoscopic sinus surgery (n=9 studies) 
 Study details Procedures and measures Findings Study contribution / limitations 
1 Study: David 
(2020)15 
Country: USA  





viral isolation drape 
(NOVID) to reduce 
aerosol and droplet 
spread in and 





Procedure(s) performed:  




Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: 
- negative pressure isolation drape 
On: Patients with unknown COVID-19 status 
(n=4) 
By: Usual clinicians (surgeon, nurse, 
anaesthetist) (n=not stated) 
Where: Operating theatre 
Procedure repetitions: microdebrider (n=2), 
drilling (n=2), cautery (n=2) 
Outcomes measured: 
Measure: 
- Aerosol presence 
- Aerosol spread 
Method:  
Key finding(s): “Our cases demonstrated there is 
minimal spread of fluorescein beyond the 
immediate surgical field.” 
Details:  
Droplets on patient: We found very little 
contamination of droplets on the patient. In all 
cases, we found fluorescent dye at sites round the 
nares and on the wipe placed on the patient's 
chest. 
Droplets on HCW:  A few droplets along the 
abdomen region and in one case a single droplet 
on the surgeon's arm. The scrub nurse had large 
droplets >5 mm on the abdomen region. 
Droplets in operating field: Droplet spread where 
the instruments or cottonoids were placed. Single 
droplet on the vertical drape “wall” at the foot of 
the patient (about 4ft from surgeon).  
 
Is the study a reasonable 
representation of real-world clinical 
practice? Yes: real-world clinical 
observation involving live patients.  
Are measurement tools appropriate 
/ robust? No: No information on 
how droplets are identified or by 
who.  
Does the study design control for 
potential confounders? No: 
Potential for false positive findings 
due to use of ‘epinephrine soaked 
cottonoids’. No control group to 
compare droplet spread without 
NOVID system. 
Other concerns? Small study. 
Limited details on outcomes, only 
presented descriptively. 
Assessments undertaken before 
and after surgery is complete so 
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 Study details Procedures and measures Findings Study contribution / limitations 
Ultraviolet examination of fluorescein 
droplets on surgical drapes and gowns. 
Note: particles were captured by 
connecting tubing to the smoke evacuator 
manifold port on a Neptune suction system 
to provide a negative pressure chamber.  
 
2 Study: Guderian 
(2020)16  
Aim: “To develop 
an experimental 
setup for the 
simultaneous 
assessment of 
aerosol and particle 
formation in 
various typical ENT 
interventions.” 
Country: Germany  
Design: Simulation 
using ‘porcine soft 
and hard tissues’ 
using video 
recording 
Procedure(s) performed:  
Procedure(s) evaluated:  
- non-powered instrument (without 
suction) 
- non-powered instrument (with suction) 
- Laser treatment 
- drilling 
- cautery 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated:  
- Suction 
On: fresh porcine tissue (bone and muscle) 
in a test chamber (n=N/A) 
By: Not reported (n=not reported) 
Where: Not reported 
Procedure repetitions: n=ADD 
Outcomes measured: 
Measure:  
Key findings: “In contrast to sole mechanical stress 
with passive instruments, all active instruments 
(laser, drilling and electrocoagulation) released 
particles and aerosols.” 
Details:  
Non-powered instrument without suction: No 
particle or aerosol formation detected.  
Non-powered instrument with suction: No particle 
or aerosol formation detected. 
Laser treatment: Droplets – A highly directed 
ejection of very fine droplets was observed under 
microscope. Aerosols - Laser-induced aerosol 
formation “considerable and surpassed all other 
surgical intervention techniques”.  
Drilling: Droplets – “clearly detectable particles”. 
Aerosols – “effect represented a spray mist rather 
than a gaseous aerosol.” 
Cautery: Droplets – “strongest effect in comparison 
to all other intervention techniques”. Aerosols – 
“considerable aerosol formation”. 
Is the study a reasonable 
representation of real-world clinical 
practice? No: Experimental 
simulation, influence of breathing 
and nasal secretions not accounted 
for. Test chamber does not 
correspond to the spatial 
dimensions of an oral or nasal 
cavity. Experiments undertaken for 
3 minutes only – unclear if 
consistent with real-world 
procedure duration.  
Are measurement tools appropriate 
/ robust? Unclear: Good reliability – 
“To eliminate inter- and 
intraobserver variability, 
measurements were performed 
fully automatic with different 
computer based algorithms”. But 
unclear how sensitive video footage 
will be to capture aerosols, 
particularly smallest size. 
Does the study design control for 
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 Study details Procedures and measures Findings Study contribution / limitations 
- Droplet size 
- Droplet number 
- aerosol density 
 
Method: Droplets photodocumented with a 
digital microscope (20 × magnification), 
software used to assess findings. 
Aerosols recorded with a Full-HD camera at 
25 frames per second.  Video post-
processed frame by frame, software used to 
assess findings. 
Procedures performed and 
measures taken in ‘test chamber’ so 
outcomes are highly likely to be 
attributable to procedure. Test 
chamber removes influence of 
ventilation. Procedure duration 
reported and consistent across 
interventions. 
Other concerns? Limited details re 
computer software programme.  
3 Study: Jones 
(2020)17  
Country: UK 
Aim: To investigate 




reduce the risk of 
intraoperative 






Procedure(s) performed:  
Procedure(s) evaluated:  
- Rigid endoscope (with suction mask) 
- Microdebrider (with / without suction 
mask) 
- Drilling (with and without suction mask) 
- External activation of powered 
instruments (within suction mask) 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: 
- negative pressure mask 
On: Cadaver (n=1) 
By: Usual clinician (surgeon) (n=1) 
Where: Laboratory 
Key findings: “The use of a negative-pressure mask 
technique resulted in 98% reduction in the fine 
particulate aerosol simulation and eliminated 
larger respiratory droplet spread during simulated 
ESS [endoscopic sinal surgery], including during 
external drill activation.”  
Details:  
Rigid endoscope: “Significant emission of 
aerosolized particles without a mask [no procedure 
performed]”. Use of suction mask “resulted in a 
98% reduction […] addition of an endoscope to the 
setup did not alter this.” 
Microdebrider: “No fluorescein droplets were 
observed with or without the negative-pressure 
mask during the simulation of powered 
microdebrider-assisted ESS.” 
Drilling: “External droplet spread was observed up 
to the 10-cm mark during the powered drilling 
Is the study a reasonable 
representation of real-world clinical 
practice? No: Cadaveric simulation, 
influence of breathing and nasal 
secretions not accounted for.  
Are measurement tools appropriate 
/ robust? Unclear: Unclear how 
appropriate smoke is as a proxy for 
aerosols. No information on how 
droplets are identified or by who.  
Does the study design control for 
potential confounders? Unclear: A 
noise reference image [for smoke 
scenario] was captured before each 
scenario and adjusted for in 
analysis. The drape [droplet 
scenario] was washed down 
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 Study details Procedures and measures Findings Study contribution / limitations 




- Droplet presence 
- Aerosol presence 
Method: Aerosols simulated using smoke 
and captured by digital camera; findings 
assessed by software. Droplets measured 
using ultraviolet examination of fluorescein 
on surgical drape covering cadaver. 
simulation, despite the use of a cutting burr with 
integrated suction […] when the procedure was 
repeated with the negative pressure mask, no 
contamination was observed” 
External activation of powered instruments:  “We 
activated the drill external to the cadaver but 
within the mask instrument aperture, both with 
and without negative pressure. Significant 
contamination was observed within the mask, but 
none was evident externally.” 
if checked with ultraviolet for 
residual droplets. 
Other concerns? Small study. 
4 Study: Murr 
(2020a)31  
Country: USA  










Procedures performed:  
Procedure(s) evaluated:  
- Non-powered instrument with suction 
- microdebrider 
- drilling 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: N/A 
On: COVID-19 negative patients. 
By: Usual clinician(s) (surgeon, nurse, 
anaesthetist).  
Where: Standard operating theatre. 
Procedure repetitions: 133 measures during 
N=5 surgeries: 
3 skull based tumour, 1 orbital abscess and 
1 functional endoscopic sinus surgery 
Key findings: Drilling and microdebrider use, but 
not non-powered instrumentation, were 
associated with a significant increase in airborne 
particle concentrations. The increased 
concentrations were localized to the area of the 
operating surgeon.  
Details:  
Non-powered instrumentation: Significant increases 
in airborne particle concentration were not seen 
for non-powered instrumentation with suction 
(mean change = 716 p/ft3; p=0.340).  
Microdebrider: Significant increases in airborne 
particle concentration were measured at the 
surgeon position with the microdebrider (mean 
change =1825 p/ft3; p=0.001)  
Drilling: Significant increases in airborne particle 
concentration were measured at the surgeon 
Is the study a reasonable 
representation of real-world clinical 
practice? Yes: live patient 
procedures in standard operating 
room.  
Are measurement tools appropriate 
/ Robust? Unclear: Particle sizer 
calibrated to national standards; 
repeated measures, 133 
measurements made during 5 
surgeries. 73% of particles were 
near the lower limit of detection (3 
um) where counting efficiency of 
instrument is 50% and the size 
distributions indicate that a 
significant fraction is less than 0.3 
μm.    
Does the design control for potential 
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 Study details Procedures and measures Findings Study contribution / limitations 
Outcomes measured:  
Measure(s):  
- Aerosol concentration 
- Aerosol spread (measurements collected 
at 3 positions: 1) the operating surgeon 
position, 2) the circulating nurse position, 
and 3) the anaesthesia provider position.) 
Method:  
Optical particle counter / sizer (Extech 
VPC300).  
position with the drill (mean change = 2418p/ft3;  
p=0.001),  
Non-surgeon positions: Particle concentration did 
not significantly increase at the anaesthetist 
position or the nurse position with any form of 
instrumentation. 
concentrations compared to pre-
instrumentation levels.  
Other concerns? “The localized 
particle effect described in this 
study quantifies aerosol 
concentrations at distinct positions, 
and therefore is limited in 
describing exposure risk to staff 
who move about freely in the 
operating room, such as the nurse.” 
 
5 Study: Sharma 
(2020a)19  
Country: USA  





surgery with and 
without 
interventions 






Procedure(s) performed:  
Procedure(s) evaluated:  
- Non-powered instrument  
- Microdebrider  
- Drilling  
- Electrocautery  
- Ultrasonic aspirator 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: N/A 
- rigid suction 
- suction ring 
- surgical smoke evacuation system 
On: Cadaver head specimen (n=1) 
By: Usual clinician (rhinologist) (n=1) 
Where: Dedicated surgical laboratory 
Key findings: All procedures “generated a 
statistically significant increase in the number 
concentration of aerosols […] 3 passive suction 
interventions all significantly reduced aerosols in 
multiple size ranges for all the tested surgical 
conditions. Among these, the surgical smoke 
evacuation system appeared to be the most 
effective in mitigating aerosol generation.”  
Details: 
Non-powered instrument: FESS [Functional 
Endoscopic Sinus Surgery] with nonpowered 
instrumentation (cold FESS) generated a 
statistically significant increase in total aerosols 
(mean difference, 1.29 particles/cm3; P \ .001), and 
there was a significant increase in the size range of 
0.30 to 0.37 µm (P <.001). Use of the surgical 
smoke evacuation system resulted in significantly 
decreased aerosol concentrations (P <.001) as 
compared with FESS with no suction (P = .27) and 
Is the study a reasonable 
representation of real-world clinical 
practice? No: Cadaveric simulation, 
influence of breathing and nasal 
secretions not accounted for.   
Are measurement tools appropriate 
/ robust? Unclear: Particle sizer 
which was calibrated before and 
after sampling. However, the lower 
detection limit of the aerosol 
instrument was 0.3 μm below 
which many particles are likely to 
reside given that 0.3 μm contained 
the largest fraction of particles 
measured. 
Does the study design control for 
potential confounders? Yes: Prior to 
each experiment, background 
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 Study details Procedures and measures Findings Study contribution / limitations 
Procedure repetitions: Non-powered 
instrument and microdebrider 5 minutes 




- Aerosol concentration 
- Aerosol size 
Method: Optical particle counter / sizer 
(OPS 3330; TSI Inc).  
as compared with FESS with the ring suction (P = 
.07). 
 
Microdebrider: There was no significant difference 
in total particle concentration during FESS 
performed with powered suction microdebrider as 
compared with baseline (mean difference, –0.025 
particles/cm3; P = .83). Both suction interventions 
resulted in decreased aerosol concentrations at 
larger particle sizes but increased concentrations at 
smaller particle sizes as compared with the 
suctioning microdebrider alone  
Drilling: High-speed endonasal powered drilling of 
the sphenoid rostrum generated a significant 
increase in total aerosol concentration as 
compared with baseline (mean difference, 11.44 
particles/cm3; P<.001) with significant increases of 
particles ranging from 0.30 to 2.69 µm. All 3 
suction intervention conditions had significantly 
decreased aerosol concentrations as compared 
with no suction (P<.001). 
Cautery: Needle tip electrocautery of the nasal 
mucosa along the septum and inferior turbinate 
without suction demonstrated a significant 
increase in total aerosol concentration as 
compared with baseline (mean difference, 1.58 
particles/cm3; P<.001). Rigid suction plus the 
surgical smoke evacuation system resulted in the 
greatest decrease in aerosol generation, with 
concentrations significantly lower than rigid suction 
alone in 10 particle size ranges (P = .015).  
measured every second for 1 
minute. HEPA filtration system used 
between experiments to return 
aerosol level to baseline and allow 
for detection of low particle 
concentrations. Particle sizer 
positioned to accurately represent 
the aerosol risk to the operating 









Tables 1 to 6: Evidence tables for included studies 
10 
 
 Study details Procedures and measures Findings Study contribution / limitations 
Ultrasonic aspirator: The use of an ultrasonic 
aspirator on frontal bone resulted in significant 
increases in total aerosol concentration (mean 
difference, 4.41 particles/cm3; P < .001). 
Conditions from both the rigid suction plus suction 
ring and the rigid suction plus surgical smoke 
evacuation system had significantly decreased 
aerosol concentrations as compared with the rigid 
suction alone. 
Surgical evacuation smoke system was used 
with rigid suction for drilling / cautery but 
not for the nonpowered instrument FESS and 
microdebrider. 
 
6 Study: Sharma 
(2020b)20  













Procedure(s) performed:  
Procedure(s) evaluated:  
- Nasal endoscope 
- Non-powered instrument 
- microdebrider  
- drilling (with and without suction) 
- external activation of powered 
instruments 
- ultrasonic aspirator 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: 
- suction used with drilling 
On: Cadaver head specimen (n=2) 
Key findings:  “Our results indicate that there is 
very little droplet generation from routine 
rhinologic procedures. The droplet generation 
from drilling was mitigated with the use of 
concurrent suction. Extreme caution should be 
used to avoid activating powered instrumentation 
outside of the nasal cavity, which was found to 
cause droplet contamination.” 
Details:  
Nasal endoscope: No observable fluorescein 
droplets were noted in the measured surgical 
field in any direction.  
Non-powered instrument: No observable 
fluorescein droplets were noted in the 
measured surgical field in any direction for FESS 
Is the study a reasonable 
representation of real-world clinical 
practice? No: Cadaveric simulation, 
influence of breathing and nasal 
secretions not accounted for.  
Are measurement tools appropriate 
/ robust? Unclear: All 
measurements were performed 
independently by 3 evaluators. The 
authors note that instead of a 
complete 360-degree assessment, 
the design model allowed for 
measurements only in the cardinal 
directions surrounding the 
specimen.  Measurement technique 
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 Study details Procedures and measures Findings Study contribution / limitations 
By: Usual clinician (surgeon) (n=1) 
Where: ‘dedicated surgical laboratory’ 
Procedure repetitions: n=1 for most 
procedures, n=2 for non-powered 
instrument and microdebrider 
Outcomes measured: 
Measure(s):  
- Droplet number 
- Droplet size 
- Droplet distance 
Method:  
Ultraviolet light examination of fluorescein 
around operating table and on surgeon’s 
chest and face shield. Evaluators counted 
and recorded the number, size, and 
distance of any illuminated fluorescent 
spots. 
[functional endoscopic sinus surgery] performed 
with cold [non-powered] instrumentation. 
Microdebrider: No observable fluorescein 
droplets were noted in the measured surgical 
field in any direction for septoplasty with 
microdebrider-assisted turbinoplasty. Limited 
droplet spread was noted under microdebrider 
FESS (2 droplets within 10 cm of cadaver head, 
all less than 1 mm in size). 
Drilling (with and without suction): No 
observable fluorescein droplets were noted in 
the measured surgical field in any direction for 
drilling of the sphenoid rostrum with a cutting 
burr, drilling of the frontal beak with a diamond 
burr, drilling of the sphenoid rostrum with a 
diamond burr with concurrent suction and 
drilling of the frontal beak with concurrent 
suction. Limited droplet spread was noted under 
drilling of the sphenoid rostrum with a diamond 
burr (8 droplets within 12 cm of cadaver head, 
all less than \1 mm in size) and drilling of the 
frontal beak with a cutting burr (5 droplets 
within 9 cm of cadaver head,\1 mm in size).  The 
use of a concurrent suction while drilling 
resulted in no contamination. 
External activation of powered instruments: 
Limited droplet spread was noted under control 
condition of the drill placed outside the nose 
(0.5 cm droplet on chest, 11 spots within 13 cm, 
largest 2 cm in size). 
Measurement of droplets only – no 
evidence on very small or airborne 
particles. 
Does the study design control for 
potential confounders? No: Authors 
do not report assessments pre-
experiment to ensure any baseline 
droplets not associated with the 
procedure are accounted for.  
Other concerns? Most procedures 
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 Study details Procedures and measures Findings Study contribution / limitations 
Ultrasonic aspirator: No observable fluorescein 
droplets were noted in the measured surgical 
field in any direction for ultrasonic aspirator on 
the left sphenoid sinus, use of the ultrasonic 
aspirator on the right frontal sinus, and external 
activation of the ultrasonic aspirator. 
7 Study: Workman 
(2020a)21 
Country: USA  
Aim: “To assess 
nasopharyngeal 













Procedure(s) performed:  
Procedure(s) evaluated:  
- Drilling (with and without suction) 
- Electrocautery (with and without 
suction) 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: 
- suctioning 
On: Cadaver head (n=2) 
By: Not reported (n=not reported) 
Where: Laboratory 
Procedure repetitions: Each procedure 
performed in duplicate.  
Outcomes measured: 
Measure:  
- Aerosol number 
- Aerosol size 
- Aerosol concentration 
Method: Optical particle counter / sizer 
(OPS 3330; TSI Inc, Shoreview, MN).  
Key findings: “The use of nasopharyngeal 
suctioning via the contralateral nostril minimizes 
airborne particulate spread during simulated 
sinonasal drilling and cautery.” 
Details: 
Drilling without suction: Significant particulate 
generation in the 1-μm to 10-μm range during 
drilling of sphenoid rostrum (p <0.001, U = 56, 
difference between medians = 120.5 particles/L) 
and anterior nasal septum/anterior medial 
maxillary wall (p < 0.001, U = 26, difference 
between medians = 403.6 particles/L, Mann-
Whitney U test) 
Drilling with suction: With the suction turned on 
throughout the drilling period, significant 1-μm to 
10-μm airborne particulate generation over 
baseline concentrations was not observed in either 
posterior or anterior drilling conditions. 
Electrocautery without suction: Significant airborne 
particulate generation in the 1-μm to 10-μm range 
was observed in the 60-second period following 
electrocautery (p < 0.001, U = 0, difference 
between medians = 120.5 particles/L), compared 
to matched-condition background levels. 
Is the study a reasonable 
representation of real-world clinical 
practice? No: Cadaveric simulation, 
influence of breathing and nasal 
secretions not accounted for. 
Are measurement tools appropriate 
/ robust? Unclear: Particle sizer. The 
methods are appropriate for 1 μm 
to 10 μm diameter size range. 
However, droplets (larger particles) 
are not measured as the authors 
point out. Especially close to the 
source larger particles could dry 
further and reduce in size. Figure 4 
suggest particle numbers are non-
zero at the upper size range. When 
scaled by volume of particles, the 
majority of the volume may be at 
higher sizes. 
Does the study design control for 
potential confounders? Yes: Prior to 
each simulation event, background 
sampling was obtained. Baseline 
airborne particulate concentrations 
were reached and measured prior 
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 Study details Procedures and measures Findings Study contribution / limitations 
Electrocautery without suction: With suction on, 
particulate generation in this range did not 
significantly differ from matched background levels 
during or following electrocautery. 
used to evacuate any retained 
intranasal particulates following all 
drilling and cautery conditions. 
Other concerns? Limited data / 
repetitions. Difference between 
medians value for Electrocautery 
without suction appears identical to 
value for Drilling without suction 
and may be a typographical error. 
The short time for electrocautery (1 
min) relative to drilling (5 min) 
result in concentrations rising after 
the cessation of electrocautery. 
8 Study: Workman 
(2020b)22 
Country: USA  







simulation  using 
particle counter 




Procedure(s) performed:  
Procedure(s) evaluated:  
- Nasal suctioning 




Patient behaviour(s) evaluated: N/A  
Device(s) evaluated: N/A 
On: Cadaver head (n=2),  
By: Not reported (n=not reported) 
Where: Laboratory 
Procedure repetitions: Each intervention 
was performed in duplicate on 2 separate 
cadaver heads. 
Key finding: “Transnasal drill and cautery use is 
associated with significant airborne particulate 
matter production in the range of 1 to 10 µm under 
surgical conditions.”  
Details:  
Nasal suctioning: Did not produce significant 
detectable airborne aerosols in the range of 1 to 10 
µm.  
Non-powered instrument: Did not produce 
significant detectable airborne aerosols in the 
range of 1 to 10 µm. 
Microdebrider: Did not produce 1- to 10-µm 
airborne aerosols over 10 sampling periods (5 
minutes). 
Drilling: 3 separate drilling conditions were 
performed: Suction drill at 12,000 rpm; Diamond 
drill at 70,000 rpm; and Cutting drill at 70,000 rpm. 
Is the study a reasonable 
representation of real-world clinical 
practice? No: Cadaveric simulation 
of surgery; no accounting for 
patient breathing / secretions. 
Volunteer-based clinical simulations 
do not account for patient 
characteristics – e.g. fever, 
increased secretions etc. 
Are measurement tools appropriate 
/ robust? Unclear: Optical particle 
sizer able to measure particles from 
1 to 10 µm.  However, droplets 
(larger particles) are not measured 
as the authors point out. In 
addition, the lower detection limit 
of 1um may have precluded 
measurement of a large number of 
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 Study details Procedures and measures Findings Study contribution / limitations 
nasendoscopy – see 




Method: Optical particle counter / sizer 
(OPS 3330; TSI Inc).  
In all 3 conditions, significant airborne aerosol 
generation in the range of 1 to 10 µm was 
observed. (P < .001 Mann-Whitney U test).  
Electrocautery: Transnasal electrocautery of the 
inferior turbinate demonstrated significant particle 
generation in the range of 1 to 10 µm over 
background in four 30-second samples (P < .001; 
Mann-Whitney U test).  
 
counts by size (see figure 1c) are at 
the lowest end of the scale.  Does 
the study design control for 
potential confounders? Yes: 
Baseline aerosols measured, 
between experiments allow for 
verification of return to baseline 
concentrations. Suction utilized to 
evacuate any retained intranasal 
particulates following drilling and 
electrocautery. The clinical 
examination room (111 sq ft) and 
the surgical laboratory (726 sq ft) 
were equipped with air exchangers 
operating at a rate of 6 total air 
changes per hour. 
Other concerns? The choice of units 
for the results (particle counts by 
size over a period of timed data 
rather than concentration) prevents 
comparison with other studies and 
a quantitative assessment of how 
much aerosol was generated or 
what the representative 
concentrations were. 
9 Study: Workman 
(2020c)23 
Country: USA   
Aim: “To simulate 
nasal 
aerosolization 
Procedure(s) performed:  
Procedure(s) evaluated:  
- Rigid nasendoscopy 
- Suctioning 
- Non-powered instrument 
- Microdebrider 
Key findings: “Cold surgical [non-powered] 
instrumentation and microdebrider use pose 
significantly less aerosolization risk than a high-
speed drill.” 
Details: 
Is the study a reasonable 
representation of real-world clinical 
practice? No: Cadaveric simulation 
of surgery; no accounting for 
patient breathing / secretions. 
Authors note that the atomizer 
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 Study details Procedures and measures Findings Study contribution / limitations 






simulated […] in 
the presence or 











nasendoscopy – see 
table 4 for details. 
 
- External activation of microdebrider 
- Drilling 
- External  activation of drill 




On: Cadaver head (n=1) 
By: Not reported (n=not reported) 
Where: Laboratory. 
Procedure repetitions: Not reported.  
Outcomes measured: 
Measure: Aerosols 
Method: Fluorescein solution (0.2 mg per 10 
mL) and quantified using a blue-light filter 
and digital image processing. Images 
assessed using ImageJ software  
Nasal endoscopy: No fluorescein-stained droplets 
were observed with a 0-degree endoscope.  
Suctioning: No fluorescein-stained droplets were 
observed from nasal suctioning with 8-French 
Frazier suction.  
Non-powered instrument: No fluorescein-stained 
droplets were observed from through-biting of the 
middle turbinate. 
Microdebrider: No fluorescein-stained droplets 
were observed from suction microdebrider 
applied to the posterior septum.  
External activation of microdebrider: No 
fluorescein-stained droplets were observed from 
external activation after tissue soilage.  
Drilling: High-speed drill at 70,000 rpm with a 5-
mm cutting to remove bone at the sphenoid 
rostrum and nasal beak resulted in droplets 
observed in multiple distribution regions between 
6 and 30 cm away from the nare. Maximum 
fluorescence intensity was significantly different in 
affected areas in the drilling conditions compared 
with baseline (p <0.01, two-tailed t test). 
External activation of drill: External drilling had 
significantly more distribution regions affected 
than non-drill surgical conditions (p < 0.05, 
Fisher’s exact test). 
Simulated sneeze with mask devices: Our data 
confirm that a simulated sneezing event can 
generate aerosols that settle maximally between 
30 cm from the nare but can extend up to 66 cm. 
that smaller particles of concern for 
airborne transmission were not 
formally assessed. There are few 
details on the atomisation and the 
provided reference does not 
provide relevant details. 
Are measurement tools appropriate 
/ robust? Unclear: Unblinded review 
of presence or absence of 
fluorescent aerosolized droplet 
contamination verified by 2 
separate authors. Authors note that 
it is possible that the microdebrider 
was capable of producing aerosols 
below estimated size detection limit 
of 20 μm.  
Does the study design control for 
potential confounders? Yes: 
Background fluorescence from a 
matched control condition was 
subtracted.  
Other concerns? Limited detail on 
methodology and appears that each 
procedure may have been 
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 Study details Procedures and measures Findings Study contribution / limitations 
Spread of these aerosols was effectively 
prevented by both the intact and VENT mask 
conditions.  
 
Table 4: Primary research on outpatient nasendoscopy (n=4 studies) 
 Study details Procedures and measures Findings Study contribution / limitations 
1 Study: Murr 
(2020b)18  
Country: USA  











Procedure(s) performed:  
Procedures evaluated:  
- Rigid endoscope  
- Non-powered instrumentation 
- Suction instrumentation 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: N/A 
On: COVID-19 negative patients. (n=30) 
By: Usual clinician (surgeon) (n=not 
reported) 
Where: “Office-based” 
Procedure repetitions: 11 nasal 
endoscopies, 19 nasal endoscopies with 
debridement, 119 measurements. 
Outcomes measured: 
Measure:  
- Aerosol concentration 
Method:  
Key findings: “Diagnostic nasal endoscopy with a 
rigid endoscope is not associated with increased 
particle aerosolization in patient for whom 
sinonasal debridement is not needed. In patients 
needing sinonasal debridement, endonasal cold 
[non-powered] and suction instrumentation were 
associated with increased particle aerosolization.” 
Details:  
Rigid endoscope [during diagnostic endoscopy]: 
Mean particle concentration 6,021 p/ft3. 
Nonsignificant mean difference of −173 p/ft3 (95% 
CI −1,139 to 793; P = .698) compared to pre-
procedure concentrations.  
Non-powered instruments [during nasal endoscopy 
with debridement]: Mean particle concentration 
8,002 p/ft3. Significant mean increase of 2,462 p/ft 
(95% CI 837 to 4,088; P = .005) from pre-
procedure levels.  
Suction instrumentation [during nasal endoscopy 
with debridement]: Mean particle concentration 
8,514. Significant mean increase of 2,973 p/ft (95% 
Is the study a reasonable 
representation of real-world clinical 
practice? Yes: real-world clinical 
observation involving live patients.  
Are measurement tools appropriate 
/ robust? Unclear: Particle sizer 
calibrated to national standards. 
The sizer was not able to detect 
particles below 0.3um which was 
the size of most particles measured 
(72%). The instrument used has a 
50% counting efficiency at these 
concentrations.  
Does the study design control for 
potential confounders? Unclear: 
Aerosol concentrations compared 
to pre-instrumentation levels. 
However, the setup was not shown 
schematically and sampling location 
with respect to ventilation can have 
an effect on particle concentrations 
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 Study details Procedures and measures Findings Study contribution / limitations 
Optical particle counter (Extech VPC300). CI from 1,419 to 4,529; P = .001) compared pre-
procedure levels. 
Rigid endoscope [during nasal endoscopy with 
debridement]: Mean particle concentration 7,169 
p/ft3. Nonsignificant but trended mean increase of 
1,629 p/ft3 (95% CI −96 to 3,354; P = .063) from 
pre-procedure levels.  
concentrations in the room rather 
than at the source. 
2 Study: Tan (2020)30 
Country: Singapore 











Procedure(s) performed:  
Procedure(s) evaluated:  
- Nasendoscope (with and without 
cophenylcaine spray decongestion) 





- Tongue protrusion 
Device(s) evaluated: N/A 
On: Volunteers (n=3) 
By: Not reported (n=not reported) 
Where: Laboratory 
Procedure repetitions: Unclear 
Outcomes measured: 
Measure: Droplets 
Method: Digital camera at 60 frames per 
second. Illumination provided through a 
Key findings: “Our study demonstrates that 
droplets clearly form under three scenarios during 
nasendoscopy.”  
Details: 
Nasendoscope: Video analysis reveals droplet 
formation in three manoeuvres during 
nasendoscopy - sneezing, vocalization, and nasal 
decongestion spray. A capillary bridge of mucus 
can be seen when a nasendoscope exits wet nares. 
Is the study a reasonable 
representation of real-world clinical 
practice? Unclear: Performed with 
‘healthy volunteers’, unclear how 
aerosol production might be 
affected in patients with a viral 
infection. 
Are measurement tools appropriate 
/ robust? No: Authors note that A 
technical limitation of our study is 
that our equipment can only 
adequately assess droplet 
formation. Aerosols below 10 μm 
(10 μm) are unlikely captured in the 
images. 
Does the study design control for 
potential confounders? Unclear: No 
information provided on 
accounting for background / 
baseline levels.  
Other concerns? Limited detail 
provided about this study. Findings 
not reported for cough, tongue 
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 Study details Procedures and measures Findings Study contribution / limitations 
green laser light. Relevant frames combined 
into one image. 
Aerosols labelled in one figure 
appear to come directly from the 
nasal spray rather than the patient. 
Unclear whether nasendoscopy 
was rigid or flexible. 
3 Study: Workman 
(2020b)22 
Country: USA  






and (2) determine 
the relative efficacy 










surgery – see table 
4 for details. 
 
Procedure(s) performed:  
Procedure(s) evaluated:  
- Rigid nasendoscopy 
- Topical spray (1% lidocaine and 
oxymetazoline 0.05% solution) 
Patient behaviour(s) evaluated: 
- Coughing 
- Sneezing 
- Heavy breathing 
- Speech 
Device(s) evaluated: 
Simulated sneezing evaluated with patient 
use of 
- Standard level 1 surgical mask 
- N95 surgical mask 
- modified N95 VENT respirator (valved 
endoscopy of nose/throat) 
- Removal of N95 mask 30 seconds after 
sneeze – to evaluate aerosol release 
On: healthy volunteers (n=2) 
By: Not reported (n=not reported) 
Key finding: “During simulated clinical activity, 
airborne aerosol generation was seen during nasal 
endoscopy, speech, and sneezing. Intact or VENT-
modified N95 respirators mitigated airborne 
aerosol transmission, standard surgical masks did 
not.”  
Details:  
Nasal endoscopy: Nasal endoscopy generated 
significant airborne aerosols (P < .05, U = 10, n = 8; 
Mann-Whitney U test). 
Topical spray: Airborne aerosols comparable to 
those generated with sneezing (P<.01, U = 0, n = 4; 
Mann-Whitney U test). 
Patient behaviours: Panting and coughing 
generated detectable 1- to 10- µm aerosols that 
were not significantly greater than background. 
Speech generated significant airborne aerosols (P < 
.01, U = 6.5, n = 10; Mann-Whitney U test). 
Simulated sneezing generated the most airborne 
particles per minute by an order of magnitude (P < 
.01, U = 0, n =4; Mann-Whitney U test). 
Simulated Sneeze Under Masked Conditions:  
Surgical mask alone attenuated airborne aerosol 
generation; however, statistically significant 
aerosol escape was still detected (P<.05, U = 2, n = 
Is the study a reasonable 
representation of real-world clinical 
practice? No: Volunteer-based 
clinical simulations do not account 
for patient characteristics – e.g. 
fever, increased secretions etc. 
Are measurement tools appropriate 
/ robust? Yes: Optical particle sizer 
used and measures particles in 
range of 1- to 10- µm.   
Does the study design control for 
potential confounders? Yes: 
Baseline aerosols measured, 
between experiments allow for 
verification of return to baseline 
concentrations. The clinical 
examination room (111 sq ft) and 
the surgical laboratory (726 sq ft) 
were equipped with air exchangers 
operating at a rate of 6 total air 
changes per hour. 
Other concerns? The choice of units 
for the results (particle counts by 
size over a period of timed data 
rather than concentration) 
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 Where: In a ‘clinical examination room’ 
Procedure repetitions: Each intervention 




Method: Optical particle counter / sizer 
(OPS 3330; TSI Inc).  
4; Mann-Whitney U test). N95 respirator and 
modified N95 VENT respirator ameliorated 
airborne particle generation to background levels. 
N95 doffing following simulated sneezing did not 
reach significance above background. 
studies and a quantitative 
assessment of how much aerosol 
was generated or what the 
representative concentrations 
were. 
Although the text says that 
airborne aerosols from Topical 
spray are comparable to those 
generated with sneezing, Fig 2C 
suggests this is higher than 
sneezing with no mask by an order 
of magnitude.  
4 Study: Workman 
(2020c)23 
Country: USA   
Aim: “To simulate 
nasal 
aerosolization 






simulated […]  in 
the presence or 




Procedure(s) performed:  
Procedure(s) evaluated:  
- Rigid nasendoscopy 
Patient behaviour(s) evaluated: 
- Sneezing (with and without masks) 
Device(s) evaluated: 
- Surgical mask 
- surgical mask with perforation to allow 
the passage of an endoscope;  
- modified valved endoscopy of the nose 
and throat (VENT) mask 
On: Cadaver head (n=1) 
By: Not reported (n=not reported) 
Where: Laboratory. 
Key findings: “Among outpatient conditions, a 
simulated sneeze event generated maximal 
aerosol distribution at 30 cm, extending to 66 cm. 
Both an intact surgical mask and a modified VENT 
mask eliminated all detectable aerosol spread.” 
Details: 
Nasal endoscopy: No fluorescein-stained droplets 
were observed with a 0-degree endoscope.  
Simulated sneeze: Our data confirm that a 
simulated sneezing event can generate aerosols 
that settle maximally between 30 cm from the 
nare but can extend up to 66 cm. 
Simulated sneeze with mask devices: Spread of 
these aerosols was effectively prevented by both 
the intact and VENT mask conditions.  
Is the study a reasonable 
representation of real-world clinical 
practice? No: There are few details 
on the atomisation (simulated 
sneeze) such that it is difficult to 
determine the representativeness 
of the findings. However, the 
authors note that because the 
atomizer produces sprays between 
30 and 100 μm smaller particles of 
concern for airborne transmission 
were not formally assessed. 
Are measurement tools appropriate 
/ robust? Unclear: Unblinded 
review of presence or absence of 
fluorescent aerosolized droplet 
contamination verified by 2 
separate authors. There is no 
reference made to previous studies 
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surgery – see table 
4 for details. 
 
Procedure repetitions: Not reported.  
Outcomes measured: 
Measure: Aerosols 
Method: Fluorescein solution (0.2 mg per 
10 mL) and quantified using a blue-light 
filter and digital image processing. Images 
assessed using ImageJ software  
measured droplet size appears to 
be the size of the droplet when 
deposited on the surface and there 
doesn’t appear to be a correction 
for size when airborne. 
Does the study design control for 
potential confounders? Yes: 
Background fluorescence from a 
matched control condition was 
subtracted.  
Other concerns? Limited detail on 
methodology and appears that 
each procedure may have been 
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Table 5: Primary research on suction for airway clearance* (n=6 studies) 
 Study details Procedures and measures Findings Study contribution / limitations 
1 Study: Chan (2018)24  
Country: Hong Kong  
Aim: “To estimate the 
spread of exhaled air 
during episodes of 
coughing bouts triggered 
by oro-tracheal 
suctioning.” 
Design: Simulation using 
human-patient simulator 
and smoke 
Procedure(s) performed:  
Procedure(s) evaluated:  
- bag-mask ventilation  
- episodes of coughing bouts 
triggered by orotracheal 
suctioning  
Patient behaviour(s) evaluated:  
- Coughing 
Device(s) evaluated: N/A 
On: Human patient simulator with and 
without intubation  (n=N/A) 
By: Usual clinician (various HCW) and 
medical students (n=20) 
Where: Not reported.  
Procedure repetitions: Unclear. 
Outcomes measured: 
Measure: Droplet spread.  
Method: Smoke particles of <1 μm in 
diameter, produced by a M-6000 
smoke generator were illuminated by 
a green (532 nm wavelength) laser 
light-sheet. Images were captured by 
high-definition camera.  
Key finding: “Coughing during oro-tracheal 
suctioning could produce substantial 
dispersion of potentially infected exhaled 
air. Nevertheless, suctioning reduced the 
spread of exhaled air during coughing bouts 
by >32% whereas continuous suctioning 
could reduce exhaled air distances more 
effectively than intermittent suctioning.” 
Details:  
Coughing: Exhaled air dispersion decreased 
with worsening coughing efforts. Before 
tracheal intubation, exhaled air leaked 
through the mouth to a distance of 860 ± 93 
mm during normal cough. This was reduced 
to 298 ± 43 mm in mild coughing effort and 
185 ± 19 mm with poor coughing effort, p < 
0.001. Following tracheal intubation, the 
dispersion distance of exhaled air after a 
normal cough was 460 ± 127 mm. This was 
decreased to a distance of 305 ± 77 mm in 
mild coughing effort and 188 ± 63 mm in 
poor coughing effort, p < 0.001 
Suctioning: In cases without tracheal 
intubation, continuous suctioning reduced 
spread better than intermittent suctioning, 
adjusted for coughing efforts, p < 0.001. On 
average, suctioning decreased exhaled air 
dispersion by >32% (range: 8.2–73.0%.   
Is the study a reasonable representation of 
real-world clinical practice? No: Laboratory-
based simulation. Influence of live patient 
factors such as breathing and nasal 
secretions not accounted for.  
Are measurement tools appropriate / 
robust? Unclear: Unclear how appropriate 
smoke is as a proxy for aerosols. 
Does the study design control for potential 
confounders? Yes: Subtracted the 
background intensity with images taken 
with the laser turned off. 
Other concerns? Unclear how many 
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 Study details Procedures and measures Findings Study contribution / limitations 
2 Study: Heinzerling 
(2020)25  
Country: USA  
Aim: “To better 
characterize and 
compare exposures 
among 121 HCP who did 
and did not develop 
COVID-19 following 
exposure to a patient.” 
Design: Retrospective 
cohort study 
Procedure(s) performed:  
Procedure(s) evaluated:  
- Airway suctioning 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: N/A 
On: SARS-Cov-2 patient  (n=1) 
By: Usual clinician (various HCW)  
(n=7) 
Where: Not reported.  
Procedure repetitions: Not reported. 
Outcomes measured: 
Measure: Transmission.  
Method: Nasopharyngeal and 
oropharyngeal specimen testing. 
Key finding: Airway suctioning was 
performed by seven HCW exposed to an 
infected patient; none developed SARS-Cov-
2 infection.  
Details:  
Suctioning: Airway suctioning was not 
performed by any of the 3 HCW with SARS-
CoV-2 infection, and was performed by 7 
(21%) of the 34 HCW who were exposed but 
not infected. No-one wore PPE as 
transmission based precautions not applied 
Is the study a reasonable representation of 
real-world clinical practice? Yes: Clinic-
based evaluation.  
Are measurement tools appropriate / 
robust? No: Risk of recall bias; procedure 
data are collected via interview and 
depend on how accurately HCW can recall 
what they did. 
Does the study design control for potential 
confounders? No: HCW performed 
multiple procedures so unclear which (if 
any) are responsible for infections. HCW 
may have been infected by another 
source. Only HCW who were symptomatic 
were tested for SARS-Cov-2; and only 
those tested were interviewed. There were 
many more HCW who had contact and 
deemed to be at high or medium risk of 
exposure (n=94). So there may have been 
HCW who were infected but asymptomatic 
and so would not have been tested.   
Other concerns? Very little data on 
suctioning. Data based on n=3 diagnoses of 
COVID among exposed staff.  No measure 
of duration of exposure 
3 Study: Loeb (2004)26  
Country: Canada  
Aim: “To determine risk 
factors for SARS among 
nurses who worked in 
Procedure(s) performed: 
Procedure(s) evaluated:  
- Suctioning before intubation 
- Suctioning after intubation 
Key finding: “We found that critical care 
nurses who assisted with suctioning before 
intubation and intubation of SARS patients 
were four times more likely to become 
infected than nurses who did not.”  
Is the study a reasonable representation of 
real-world clinical practice? Yes: clinic-
based evaluation.  
Are measurement tools appropriate / 
robust? No: Risk of recall bias; procedure 
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 Study details Procedures and measures Findings Study contribution / limitations 
two critical care units in 
a Toronto hospital.” 
Design: Retrospective 
cohort study 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: N/A 
On: SARS patients (n=3) 
By: Usual clinician (Nurses) (n=32) 
Where: Hospital ward / room 
Procedure repetitions: n=4 before 
intubation, n=19 after intubation 
Outcome measures: 
Measure: Virus transmission 
Method: Confirmed by antibody test.  
Details:  
Suctioning before intubation: 75% of nurses 
who performed suctioning before 
intubation were infected with SARS (3/4 
nurses) compared to 18% of nurses who did 
not perform suction prior to intubation 
(5/28 nurses). Relative risk 4.20; CI 95% 1.58 
to 11.14; P value 0.04. 
Suctioning after intubation: 21% of nurses 
who performed suctioning after intubation 
were infected with SARS (4/19 nurses) 
compared to 31% of nurses who did not 
perform suction prior to intubation (4/13 
nurses). Relative risk 0.68; CI 95% 0.21 to 
2.26; P value 0.68. 
Note: The authors report that all 3 nurses 
involved in suctioning before intubation 
who acquired SARS one reported consistent 
PPE use including N95 mask and two 
reported inconsistent PPE use.  
depend on how accurately nurses can 
recall what they did. 
Does the study design control for potential 
confounders? No: Nurses performed 
multiple procedures so unclear which (if 
any) are responsible for infections. No 
comparison of how much time nurses 
spend patient’s room. Nurses may have 
been infected by another source. 
Other concerns? Small sample size.  
4 Study: Raboud (2010)27  
Country: Canada  
Aim: “To identify risk 
factors associated with 
transmission of SARS-
CoV from patients 
requiring intubation to 
HCWs involved in their 
care.” 
Procedure(s) performed: 
Procedure(s) evaluated:  
- Suctioning before intubation 
- Suctioning after intubation 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: N/A 
On: SARS patients (n=45) 
Key finding: No evidence of association of 
suction for airway clearance with SARS 
infection.  
Details:  
Suctioning before intubation: Suctioning 
before intubation was undertaken by 27% 
of nurses infected with SARS (7/26 nurses) 
compared to 18% of uninfected nurses 
(106/598 nurses). Fishers exact test p value 
= 0.29. 
Is the study a reasonable representation of 
real-world clinical practice? Yes: clinic-
based evaluation.  
Are measurement tools appropriate / 
robust? No: Risk of recall bias. Procedure 
data from HCW recall – interviews 
conducted up to 10 months post-
procedure.   
Does the study design control for potential 
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 Study details Procedures and measures Findings Study contribution / limitations 
Design: Retrospective 
cohort study 
By: Usual clinician (various HCW) 
(n=624) 
Where: Hospital ward / room 
Procedure repetitions: n=17 
Outcome measures: 
Measure: Virus transmission 
Method: Confirmed by antibody test 
or met case definition. 
Suctioning after intubation: Suctioning after 
intubation was undertaken by 38% of nurses 
infected with SARS (10/26 nurses) 
compared to 26% of uninfected nurses 
(155/598 nurses). P value = 0.16. 
In the multivariate logistic regression model 
(to account for correlation among responses 
from HCWs caring for the same patient) 
suctioning was not found to be an 
independent predictor of SARS infection. 
Note: HCWs who contracted SARS were 
“more likely to have used less effective 
methods of respiratory protection while in a 
patient’s room (p= .04)”. There is no specific 
information about mask use during 
suctioning.  
perform procedure – they were considered 
‘exposed’ if they reported being in room 
while the patient received the procedure. 
HCW perform multiple procedures so 
unclear which (if any) are responsible for 
infection. No information on duration of 
procedures, use of PPI in relation to 
specific procedures, length of time spent in 
patients’ room. HCW may have been 
infected by another source 
Other concerns? Limited evidence about 
suctioning. 
5 Study: Thompson 
(2013)28  
Country: UK  





infectious aerosols. 2) If 
detectable clouds are 
produced then determine 
infectious aerosol 
concentration and 
particle size. 3) To use 
this information to 
Procedure(s) performed: 
Procedure(s) evaluated:  
- Respiratory & Airway Suction 
(performed during an aerosol 
generating procedure and 
compared to baseline period) 
Patient behaviour(s) evaluated: N/A 
Device(s) evaluated: N/A 
On: H1N1 patients (n=11) 
By: Usual clinician (not specified) 
(n=not reported) 
Where: Hospital ward / room 
Key findings: Respiratory/airway suctioning 
“appears to be related to an increased 
likelihood of viral aerosol generation.” 
Results indicate that respiratory and airway 
suction “tends to produce aerosols of 
smaller particle sizes than baseline levels” 
but the difference was not statistically 
significant  
Details:  
Particle size: Compared to baseline samples 
the RNA recovered during respiratory and 
airway suctioning were smaller. In baseline 
the majority of RNA (78.7%) were found in 
particles larger than 7.3 µm. In suctioning 
Is the study a reasonable representation of 
real-world clinical practice? Yes: clinic-
based evaluation.   
Are measurement tools appropriate / 
robust? Unclear: Authors report that May 
impinger does not collect particles <,0.86 
µm aerodynamic particle size, several 
studies have reported finding influenza 
RNA in air particles <,1 µm, thus it is 
possible that some of the aerosolized RNA 
was missed. 
Does the study design control for potential 
confounders? Yes: Baseline samples taken 
when no activity that could be defined as 
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 Study details Procedures and measures Findings Study contribution / limitations 
inform infection control 
practice.” 
Design: Clinical 
observation with particle 
counter 
Procedure repetitions: n=14 
Outcome measures: 
Measure:  
- Viral RNA aerosol concentration 
- Particle size  
Method: Particle counter / sizer (Glass 
May 3-stage impingers produced at 
HPA, Porton Down). PCR used to 
detect the presence of any influenza A 
RNA.  
the majority of RNA (77.6%) were found in 
particles smaller than 7.3 µm.  
Aerosol generation: An increased probability 
associated with airway suctioning but not 
statistically significant (OR = 4.11 (0.50–
34.0)).  
vaccinations mean that it is “unlikely that 
the influenza aerosols could have been 
generated by anyone other than the 
patient on whom the AGP was being 
performed.  
 
6 Study: Weber (2019)29 
Country: USA  




on surfaces and on 
participants—associated 
with seven common 
healthcare activities.” 
Design: Laboratory 
simulation using ‘task 
trainers’ and fluorescein 
Procedure(s) performed: 
Procedure(s) evaluated:  
- Suctioning to remove secretions 
Patient behaviour(s) evaluated: 
- Coughing 
- Vomiting 
Device(s) evaluated: N/A 
On: ‘task trainers’ (mannequins) (N/A) 
By: Usual clinician (various HCW) 
(n=39) 
Where: Laboratory 




Key finding: “In this study, we did not 
observe AGPs [including suctioning] to be 
associated with increased frequency of 
fluorescein in air relative to other 
activities.”  
Details: 
Droplets: Fluorescein was detected at lower 
levels on face shields and facemasks for 
suction than for other activities (bathing, 
central venous access, intravenous access, 
physical examination and vital signs 
assessment). 
Median fluorescein concentration in air 
from 10 tests at 1m (25th, 75th percentile) 
3.93ng m-3 (2.41, 6.39); not detected in 
30%. In 9 tests in personal breathing space, 
median concentration 3.16 ng m-3 (1.07, 
9.26), 75% not detected  
Is the study a reasonable representation of 
real-world clinical practice? No: Laboratory 
simulation with ‘task-trainers’. Some 
efforts to replicate real life scenarios 
however; researcher squeezed lungs to 
simulate cough/vomit and participants 
were allowed to perform the healthcare 
activities as normal, rather than following a 
detailed study protocol.  
Are measurement tools appropriate / 
robust? Unclear: Aerosols measured by 
calibrated fluorometer but no information 
on who or how many people visually 
assessed droplets or what approach was 
used to ensure completeness of data. No 
information provided about the size of 
particles detectable or the efficiency as a 
function of particle size of the Biosampler 







Tables 1 to 6: Evidence tables for included studies 
26 
 
 Study details Procedures and measures Findings Study contribution / limitations 
- Aerosols 
Method: Aerosols measured via 
Fluorescein concentration using a 
Trilogy benchtop fluorometer. 
Fluorescein droplets on the HCW’s 
body were visually assessed using 
black lights.  
Measurements taken at stationary 
point 1m from procedure and within 
the personal breathing space  
No fluorescein was detected on face or face 
shield and there was no association between 
concentration on face shield and in air 
(Spearman’s ρ = 0.09, P = 0.49) 
 
Aerosols: The difference in proportion of 
samples positive for fluorescein were not 
statistically significantly between healthcare 
activities.  
Does the study design control for potential 
confounders? Yes: Blank samples (negative 
controls) of aerosol sampling devices were 
used to correct measured values and 
sample extraction efficiency. For droplets 
measures are obtained (i) prior to the start 
of the healthcare activity (as a baseline), 
(ii) directly after the healthcare activity and 
(iii) after doffing PPE. 
Other concerns? It is difficult to justify 
comparing the different tasks 
quantitatively (amount of fluorescein in 
samples) because of the starting 
conditions. For example, for intubation 
300ml of liquid has been ‘poured through 
mouth to lungs and stomach’ compared to 
100 ml poured onto two areas of the body 
for bathing. In the latter case all of the 
fluorescein will be external, while in the 
former it may be only a small amount that 
comes into contact with the endoscope. 
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Table 6: Systematic reviews with evidence on research and guidance (n=4) 
 
Review details Findings  
Evidence limitations / 
overlap 
1 Review: Thamboo (2020)34  
Clinical evidence based review and 
recommendations of aerosol 
generating medical procedures in 
otolaryngology–head and neck 
surgery during the COVID-19 
pandemic. J. Otolaryngology-head 
and neck surgery, 2020; 49: 28-42 
Aim: “To identify potential AGMPs in 
Otolaryngology - Head and Neck 
Surgery and provide evidence-based 
recommendations.” 
Inclusion criteria: “English articles, 
clinical or experimental studies 
involving procedures in the head and 
neck region.” 
Focus on which procedures?: 
Nasogastric tube insertion: No 
Lung function tests: No 
Dysphagia assessments: No 
Nasoendoscopy / nasal cautery: Yes 
Suction for airway clearance: No 
 
Research evidence:  
Nasoendoscopy / nasal cautery:  
- Nasoendoscopy: (n=1 study) “Only one study [Workman 2020c] evaluating the 
aerosolization risk during nasal endoscopy was identified.” (See Workman 2020c in Table 3) 
- Endoscopic Sinonasal surgery: (n=1 study) “Workman et al. (2020c) investigated the 
aerosolization risk during endoscopic sinonasal procedures” (See Workman 2020c in Table 
3) 
- Electrocautery:  (n=6 studies) “Four, direct crosssectional studies, two experimental 
studies […]There is consistent, direct evidence indicating that electrocautery can result in 
small aerosols with potential spread over longer distances. It is uncertain if this can actually 
lead to clinically relevant transmission of viable pathogens.” 
Available guidance: N/A guidance not included 
 
Limitations: 




- Cautery evidence 
unclear if nasal 
cautery / non-COVID 
patients.  
Overlap: 
 Nasal Endoscopy 






Base Surgery (n=1 
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2. Review: Tran (2012)33  
Aerosol Generating Procedures and 
Risk of Transmission of Acute 
Respiratory Infections to Healthcare 
Workers: A Systematic Review. PLoS 
ONE, 2012; 7(4): e35797 
Aim: “To determine the clinical 
evidence for the risk of transmission 
of ARIs [acute respiratory infections] 
to HCWs caring for patients 
undergoing AGPs compared with the 
risk of transmission to HCWs caring 
for patients not undergoing AGPs.” 
Inclusion criteria: Design: health 
technology assessments (HTAs), 
systematic reviews, meta-analyses, 
randomized controlled trials, and non-
randomized studies. Population:  
HCWs caring for patients with acute 
respiratory infections. Intervention: 
provision of care to patients 
undergoing aerosol generating 
procedures. Comparator: provision of 
care to patients not undergoing 
aerosol generating procedures. 
Outcome: risk of transmission of 
acute respiratory infections from 
patients to HCWs. 
Focus on which procedures?: 
Nasogastric tube insertion: Yes 
Lung function tests: No 
Research evidence:  
Nasogastric tube insertion:  
“Pooled estimates suggest that […] insertion of nasogastric tube […] might be associated 
with an increased risk of transmission, but the odds ratios were not statistically significant.” 
- Nasogastric tube insertion (2 cohort studies) Pooled Estimate: Odds Ratio: 1.2; 95% CI: 
0.4- 4.0; I squared:  0%.  
Suctioning for airway clearance:  
“Pooled estimates suggest that […]suction before intubation [and] suction after intubation 
[…] might be associated with an increased risk of transmission, but the odds ratios were not 
statistically significant.” 
- Suction before intubation (2 cohort studies) Pooled Estimate: Odds Ratio: 3.5; 95% CI: 0.5- 
24.6; I squared:  59.2%.  
- Suction after intubation (2 cohort studies) Pooled Estimate: Odds Ratio: 1.3; 95% CI: 0.5- 
3.4; I squared:  28.8%.  
 
Available guidance: N/A guidance not included 
 
Limitations:  
- Limited evidence for 




The 2 studies for all 
outcomes are Raboud 
(2010) and Loeb (2004). 













Review details Findings  
Evidence limitations / 
overlap 
Dysphagia assessments: No 
Nasoendoscopy / nasal cautery: No 


























Similarity to real world 
conditions:
• Human: healthy or 






Measurement method (possible 
source of error or detection bias):






• Duration of exposure
• Proximity/location 
• Intervention (e.g., PPE)





• Patient characteristics 
(e.g., overactive gag 
reflex)
For the above, did they 
test different conditions? 
(e.g., repeat with 
different durations)
Similarity to real world 
conditions:
• Modifications from 
real practice












Records identified through 
database searching 




























Additional records identified 
through other sources 
(n = 4) 
Records after duplicates 
removed 
(n = 911) 
Records screened 
(n = 911) Records excluded  
(n = 836)   
Full-text articles assessed for 
eligibility 




(n = 55) 
 No original data 
reported (n=41)  
 Not procedure of 
interest (n=11) 
 Not virus of 
interest (n=1) 




Studies included in synthesis 
(n = 20)  
18 primary; 2 systematic 
review 
Duplicates removed  
(n = 6) 
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